Wharton _ 2015 Resume Book 2m1c30

Wharton MBA Program in Health Care Management

2015

RESUME

BOOK

Contents Program Description . . . . . . . . . . . . . . . . . . . . . . 4 Curriculum . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5 Graduates . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6-27 Internship Sponsors . . . . . . . . . . . . . . . . . . . . . . 28 Health Care Program Mentors . . . . . . . . . . . 29-32 istration . . . . . . . . . . . . . . . . . . . . . . . . . . 33 Faculty . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34-35

Thank you for your interest in the Wharton MBA Program in Health Care Management. For further information, resumes, and appointments, : June Kinney, Associate Director, MBA Program in Health Care Management The Wharton School University of Pennsylvania 3641 Locust Walk Philadelphia, PA 19104-6218 215.898.6861 | Fax 215.573.2157 email: [email protected] For information on the Wharton Health Care Management Alumni Association, visit www.whartonhealthcare.org For detailed information on the Health Care Management Department educational programs, visit http://hcmg.wharton.upenn.edu/

2015 Health Care Management M.B.A. Graduates The University of Pennsylvania was founded by Benjamin Franklin in 1740. Although the University carries the name of the Commonwealth, it is not a state university but an independent, private, nonsectarian institution. As one of the country’s earliest educational institutions, it has consistently initiated advances in teaching and research and has steadily generated specialized fields of higher education. Penn, as the University is commonly known, was the first American university to form departments of botany, hygiene and public health, surgical research, and research medicine. The University School of Medicine, formed in 1765, was the first in North America, as was the teaching hospital founded in 1874. The world’s first psychological clinic was opened at Penn in 1896. The Wharton School, in the same spirit of innovation and excellence, was the world’s first collegiate school of business and management. Founded in 1881 with a gift from Joseph Wharton, the Philadelphia industrialist and philanthropist, the Wharton School undertook the pioneer steps in elevating training for business significantly above its previous level as noncollegiate commercial education. In 1921, the formation of the Graduate Program signaled the advancement of business istration at Wharton to the highest levels of professional education. Today, the Wharton School has more than 270 faculty teaching in both the graduate and undergraduate divisions and conducting a continually expanding volume of research. The 1,700 students in the master’s degree program may choose from among more than 200 courses and over 18 majors and concentrations, a variety reflecting the fact that the Wharton education complements the career goals of the individual. This brochure is provided to introduce you to the 2015 Wharton Health Care Management Program graduates. We encourage you to consider these individuals for employment.

3

Program Description The Graduate Program in Health Care Management is a full-time two-year MBA curriculum offered by the Health Care Management Department of the Wharton School. The program, the principal educational effort at the Leonard Davis Institute of Health Economics, is designed to provide managerial and technical expertise to students interested in the health care management field. By combining the skills of the Wharton disciplines with sensitivity to the needs of health care providers and recipients, the Wharton MBA health care graduate can effectively manage the delivery of health services and products at all levels. The Program has produced graduates who have chosen careers in hospitals and other medical institutions, pharmaceutical, biotechnology and medical device companies, financial services, entrepreneurial ventures, consulting firms, insurance firms, private health industry, and federal, state, and local government. Many of these MBA graduates now hold positions as chief executive officers, directors, and other key decision makers in health care organizations.

4

The Leonard Davis Institute of Health Economics (LDI) is an interdisciplinary center for research and education in the organization, financing, and delivery of health care. Through LDI, University of Pennsylvania faculty and staff work together on issues concerning health policy, health insurance, managed care, hospitals, corporations, pharmaceutical companies, and other healthrelated organizations. Established in 1967, the Institute appropriately bears the name of the late Leonard Davis, one of the foremost innovators in private health insurance in the United States. He was the founder of Colonial Penn Group, Inc., a company that has pioneered in insurance for older Americans. Both Mr. Davis and Mrs. Sophie Davis were generous benefactors to the University of Pennsylvania, contributing basic for the activities of the Leonard Davis Institute.

Curriculum The Wharton Management Core All students are required to complete the Wharton Management Core. The Wharton School’s core curriculum is designed to increase crossfunctional integration, extend global experience, strengthen leadership training, and introduce new courses on key management issues. The core curriculum provides groundwork in basic management disciplines: economics, finance, financial and cost ing, management science, managing people and organizational design, marketing, operations management, the governmental and legal environment of business, statistics, and strategy. Fixed Core: • Foundations of Teamwork and Leadership • Marketing Management • Quality and Productivity • Regression Analysis for Business • Microeconomics for Managers • Management Communication Flexible Core: ing • Financial ing or • Financial and Managerial ing or • Accelerated Financial ing Finance: Corporate Finance • Corporate Finance or • Accelerated Corporate Finance or • Introduction to Corporate Finance Finance: Macroeconomics • Macroeconomics and the Global Economic Environment or • Introduction to Macroeconomics and the Global Economic Environment Legal Studies & Business Ethics • Responsibility in Global Management or • Responsibility in Professional Services Management • Managing the Established Enterprise or • Managing the Emerging Enterprise Marketing • Dynamic Marketing Strategy or • Strategic Marketing Simulations Operations • Business Analytics or • Information Technology and Business Transformation or • Innovation or • Operations Strategy • Communications • Advanced Persuasive Speaking or • Advanced Persuasion and Data Display or • Pitching Your Business

Global Immersion Program The Wharton Global Immersion Program is an optional half-credit elective course that provides first-year students with an in-depth exposure to international business practices and first-hand insights into a foreign culture. The Health Care Major Courses and Electives These courses promote an understanding of concepts, institutions, and issues involved in the organization, financing, and delivery of health services and products in the United States. Health care electives are selected consistent with individual career objectives and interests. Required • Health Services System • Health Care Field Application Project Electives • Comparative Health Care Systems • Financial Management of Health Care Organizations • Managed Care, Market Structure, and Health Care Delivery • Health Business and Policy • Health Care Marketing • Healthy Policy • Legal Aspects of Health Care • Management and Economics of Pharmaceutical and Biotechnology Industry • Medical Devices • Management of Health Care for the Elderly • E-Health: Business Models and Impact • Management of Health Care Services Businesses • Health Care Entrepreneurship • Private Sector Role in Global Health • Health Care Services Delivery: A Managerial Economic Approach • Advanced Study Project The Health Care Summer Internship The internship is a three-month management experience which provides the health care major an opportunity to work with a senior executive in an organization of particular interest to the student. MBA Electives Opportunities are available for the health care major to pursue a second concentration in fields such as entrepreneurship, marketing, finance, or operations, or to pursue specialized knowledge in areas such as health care financing or within specialized segments of the health care industry including managed care organizations, hospitals, pharmaceutical and biotechnology companies, medical device companies, specialty services organizations, and long term care organizations. Graduate courses are available throughout the University.

5

Matt R. Adkins

Neil Agarwal

David Allen

[email protected] University of Michigan, Ross School of Business, Ann Arbor, MI B.B.A., High Distinction, Finance and ing, 2006

A commercial marketing opportunity in the biopharmaceutical industry.

An opportunity to use my strategic and operational expertise to improve value in health care delivery.

An opportunity to build successful health care businesses through an operational or strategic role.

Deloitte Consulting, New York, NY Summer Associate, Summer 2014 Advised a major foundation in setting organization-wide strategy for $300M in health-related funding and investment. Synthesized primary and secondary research into strategy white paper to be used by other large foundations.

Medtronic, Northridge, CA Marketing Intern, Summer 2014 Designed and initiated a plan to evaluate and address cost-driven attrition in the United States for the Diabetes Business Unit. Developed a consumables marketing toolkit that was showcased at an industry conference in August 2014. Created the business case recommendation for launch of a new infusion set in early 2015.

Pfizer, New York, NY Marketing Summer Associate, Summer 2014 Led the development of a full, multi-channel, physician marketing campaign to announce the potential US approval of Palbociclib, one of Pfizer’s most highly anticipated new drug launches. Presented recommended content strategy to Business Unit Review Committee to gain alignment on strategy from a regulatory perspective. Worked with a creative advertising agency to drive the execution of individual tactics and presented proposed campaign directly to the President of North America Oncology. Simon-Kucher & Partners, Boston, MA Senior Consultant, 2012-2013 Consultant, 2009-2011 Pricing and marketing consultant for clients in the pharmaceutical, biotechnology, and medical device industries. Led project teams of 2-9 consultants on engagements providing clients with data-driven strategic recommendations on topics such as launch pricing, payer contracting, forecasting, customer segmentation, messaging strategy, distribution strategy, and patient assistance programs. Leveraged quantitative analysis techniques including multivariate regression, cluster analysis, and cont analysis to drive strategic recommendations. Presented reports and key recommendations to client teams, including senior management and C-level executives.

6

Mount Sinai Hospital, New York, NY Summer istrative Resident, Summer 2014 Recommended staff allocation modifications that increased OR utilization by 30%. Pinpointed margin contribution from surgeries using financial and medical data. Analyzed ER care processes to reduce wait times and increase revenue. Catapult Consultants, Arlington, VA Health Care Analyst, 2011-2013 Worked with Medicare & Medicaid on multiple engagements targeting care quality in hospitals and nursing homes. Developed data analysis tools; ed IT system design; created client trainings. Only analyst invited to aid senior management in new business development. U.S. Peace Corps, Bondo, Kenya Public Health Advisor, 2009-2011 Advised 4 rural hospitals on operational improvements and recommended changes to Health Ministry’s $1.2M district budget. Created health education initiative reaching 2,500 students.

Soros Fund Management, New York, NY Private Equity Associate, 2010-2013 Member of the private equity group at Soros Fund Management, the private family office of the Soros family. As part of a 16-person team managing a $3.5B portfolio, primary responsibilities were to evaluate new investment opportunities and to manage portfolio companies in a variety of industries including telecommunications, wasteto-energy and healthcare. G.F. Capital Management and Advisors, New York, NY Private Equity Associate, 2007-2010 $250M private equity fund focused on media, entertainment, and branded consumer products. Evaluated and executed potential opportunities as the sole associate resource in the organization with responsibilities including: developing financial models, leading due diligence sessions, coordinating third-party advisors, and preparing investment memorandums.

Joshua Atwood

Brian P. Belsky

Jonathan P. Brallier

[email protected] Franklin & Marshall College, Lancaster, PA B.A., Cum Laude, Finance / ing, 2007

An opportunity to build successful companies in healthcare through strategy, business development, or direct investing.

The opportunity to build successful businesses through health care focused private equity investing.

An opportunity to develop and execute innovative strategies to improve health care ecosystems.

Health Enterprise Partners, New York, NY Summer Associate, Summer 2014 Evaluated more than two dozen investment opportunities in healthcare services and IT sectors for firm’s $150M second fund. Transaction experience includes preferred equity investment in InDemand Interpreting, a provider of video remote interpretation (VRI) services to the health care provider market. Worked extensively with multiple portfolio companies to amend cash management strategy and forecast revenue bridge projections.

Booz & Company (nka Strategy&), New York, NY MBA Associate, Health Strategy Group, Summer 2014 Developed product and go-to-market strategy for the launch of a $5B consumer-directed business at a major health insurer. Determined company and product positioning through analysis of consumer data, competitive offerings, and market trends. Designed an interactive financial operating model for the future-state business.

Albright Stonebridge Group, Washington, DC External Adviser, 2014 Advised multinationals on how best to navigate complexities of investments and operations in emerging markets through commercial diplomacy and management consulting. Focused on client service and business development for finance and health care sectors. McKinsey & Company, Boston, MA Engagement Manager 2013 Senior Associate 2012 Business Analyst 2010-2012 Research Analyst 2008-2010 Led large consultant and client teams across over a dozen projects for leading life sciences, financial services, and private equity firms. Worked closely and built relationships with senior client management across industries, geographies, and cultures. Designed and managed complex projects, creating client deliverables, conducting qualitative and quantitative analysis, and coaching consultants and client executives. World Economic Forum, Geneva, Switzerland Project Manager 2012 Developed strategies and policy recommendations for Ministers of Health, Ministers of Finance, and industry leaders on health system delivery and financing. Facilitated CEO and Minister level discussions at the World Economic Forum Annual Meeting at Davos 2012 as well as 10 other half-day workshops.

Self Health Network, San Francisco, CA Chief Strategy Officer, 2013 Self Health Network is a reission avoidance-focused health care technology company. Responsibilities included leading successful fundraising effort, cultivating sales pipeline, developing new product and preparing eightquarter corporate strategic plan. Bank of America Merrill Lynch, New York, NY Associate, Health Care Investment Banking, 2010-2013 Provided financial, M&A and strategic advisory services to health care provider and managed care companies resulting in more than $1.8B in completed transactions in 3 years. Merrill Lynch & Co., New York, NY Analyst, Tax-Exempt Capital Markets, 2007-2009 Originated and traded credit products for a Merrill Lynch proprietary fixed income trading desk as well as thirdparty clients.

Falcon Capital Partners, Philadelphia, PA Senior Associate, 2009-2013 Managed merger and acquisition, strategic advisory, and growth financing assignments in the health care and information technology industries. Led investment analyses related to platform company investments on behalf of private equity clients, including Warburg Pincus and Parthenon Capital. Directly managed client relationships during several sell-side transactions, including advising clients on personal long-term goals and negotiating deal with clients and investors. Morgan Joseph, Nashville, TN Analyst, 2007-2009 Participated in the origination, analysis, and execution of merger and acquisition, fairness opinion, and general advisory assignments for clients in various industries, representing over $1B in value.

7

Colin W. Brown

Alexandra C. Burtoft

Elif Çar

[email protected] Bogazici University, Istanbul, Turkey B.A., High Honors, Management, 2008

An opportunity to work at the intersection of healthcare and technology to improve patient outcomes.

A promotional or strategic marketing opportunity focused on oncology/ hematology or rare disease within the biopharmaceutical industry.

An opportunity in consulting with exposure to the healthcare sector.

Infosys Limited, Pune, India Intern, Infosys Public Services, Summer 2014 Developed market-entry strategies to Infosys’s expansion into the US healthcare and government sectors. Worked across sales, marketing, and product development divisions to modify existing IT solutions for US market needs. Clinton Health Access Initiative Nairobi, Kenya & Kingston, Jamaica Associate, Drug Access Team, 2011-2013 Analyst, Jamaica Country Team, 2010-2011 Advised government officials in the Caribbean and Sub-Saharan Africa on opportunities to reduce HIV treatment costs and increase quality of care. Managed $3M grant covering programs and staff in Kenya, Uganda, Ethiopia, Tanzania, Nigeria, and Liberia. Collaborated with procurement agencies and regulatory authorities to accelerate the introduction of novel, life-saving commodities and mitigate impending stockouts of HIV drugs. Accretive Health, Chicago, IL Lead, Measurement Team, 2008-2010 Created complex financial models to quantify the value of Accretive’s revenue cycle initiatives. Improved accuracy of measurements allowed the company to invoice and collect on over $10M in outstanding revenue.

8

Celgene Corporation, Summit, NJ Hematology Marketing Intern. Summer 2014 Evaluated and provided recommendations for potential commercial partnerships with companies filing NDAs for a drug to be used in combination with Revlimid. Spearheaded an evaluation of the current strategy for marketing to hematology/oncology NPs/PAs and recommended specific tactics, as well as increased spend/attention to this group. Used my commercial regulatory expertise to lead the creation, review, and ad agency collaboration for both consumer- and physician-focused promotional tactics. Genentech Inc., South San Francisco, CA Associate Program Director, 2008-2014 Worked for five years full-time and for one year on a contract basis as the promotional review committee (PRC) lead for multiple brands, including Boniva, Herceptin, Perjeta, Rituxan for RA, and Tarceva. Led the product launch for Perjeta and served as the main commercial regulatory expert for cross-functional teams, including PR, brand marketing, managed care, access solutions, medical affairs, corporate communication, commercial training, etc. Pioneered the “Creating Perspective” training program to teach sales representatives about the PRC process and evolution of brand messaging. The program was nominated for a RethinkD Award for out-of-the box thinking for the betterment of the company.

Alyuta, Istanbul, Turkey Customer Development Manager, 2012-2013 Led a 4-person team to develop a cutting-edge marketing analytics tool for Turkey’s largest hospital chain and e-commerce companies. Analyzed client data and made recommendations based on customer lifecycle analytics, next-product-to-buy, and customer lifetime value models. Pfizer, Istanbul, Turkey Product Manager, 2009-2012 Project Manager 2008-2009 Responsible for developing and executing cardiovascular products’ business plans, including the cholesterollowering drug Lipitor. Developed launch plans for two different products (Eliquis, Sevikar) including regulatory, reimbursement, pricing, and marketing strategies by working closely with cross-functional partners. Planned and coordinated co-promotion business models with Bristol-Myers Squibb and Daiichi Sankyo and led regular executive meetings with country managers of both companies to ensure high level alignment. Developed Turkey’s first telemedicine project empowering physicians to track patients’ records remotely. Devised sales transformation program for Norvasc (Turkey’s best selling anti-hypertensive), which resulted in 20% unit growth and $22M sales. Identified growth potential in diabetic patients for Lipitor by consolidating market data with customer insights and led diabetes projects resulting in increased treatment rates of diabetics.

Daisy J. Carrillo

Alli Chandra

Dustin W.M. Chang

[email protected] Johns Hopkins University, Baltimore, MD B.A., Economics and Psychology, 2008

An opportunity to apply my business and technical skill set to strategic and operational roles focused on leveraging technology to lower costs, improve quality and increase access to care.

An operational, financial, or strategic transformation role with provider organizations transitioning to value-based care.

An opportunity in private equity with exposure to the healthcare industry.

Google, Mountain View, CA gTech MBA Intern, Summer 2014 Developed a model to conduct a global data analysis of Google’s technology team, providing the VP of Sales with strategic insights and recommendations related to product adoption, growth trends, and capability gaps. Analyzed data to identify key drivers of unmet service metrics, implementing 4 initiatives that led to a 53% improvement in total resolution time. Deloitte Consulting, Los Angeles, CA Consultant, 2009-2013 Primarily served health insurance clients across multiple projects in technology strategy from operations and process improvement to enterprise-wide system migrations for the Health Insurance Exchanges. Delivered a deployment strategy for a newly acquired health care benefit management application, analyzing risks and benefits of 4 potential deployment options. Additionally, conducted a fit-gap analysis of the client’s customer service team to determine the operational impacts of using a new application. Identified technical infrastructure needs, process redesign opportunities and training requirements.

McKinsey & Company, Washington, D.C. Business Technology Associate, Summer 2014 In first study, conducted market scan and fit-gap-analysis for claims product solutions for $1B government project that client is pursuing. In second study, developed framework and identified target companies for $150M HIT purchasing strategy for payer client. Center for Medicare & Medicaid Innovation, Washington D.C. Special Assistant to the Director, 2012-2013 Launched five payment programs worth $1.5B under aggressive istration deadlines by negotiating technical and press details with senior leadership in HHS and the White House. Center for Medicare & Medicaid Innovation, Washington D.C. Pioneer able Care Organization (ACO) Program Officer, 2011-2012 Received ’s Special Citation Award for exceptional work as operational lead and program officer on Pioneer model. Served as sole Medicare representative to 10 major health systems. Co-led online peer learning networks on data analytics, risk stratification, and predictive modeling. Crafted alignment algorithm, beneficiary overlap, attestation, audit, program monitoring, and reinsurance policies. Negotiated of ACO contracts with nine health systems for combined worth of approximately $10B.

Citadel Investment Group, New York, NY Global Equities Summer Associate, Summer 2014 Initiated coverage or made recommendations on five long/short positions. Developed detailed financial models to analyze potential investment opportunities. Conducted fundamental analysis through primary research; led discussions with executive management teams. Galen Partners, Stamford, CT Associate, 2011-2013 Healthcare private equity firm with approximately $1B AUM. Assessed and analyzed investment opportunities across a range of transaction types, including growth equity, leveraged buyout, and private investment in public equity; proactively sourced and screened investment opportunities. Successfully completed five new or follow-on investments and one portfolio company sale. Advised portfolio company management teams on strategic planning and business development. Stifel Nicolaus Weisel, New York, NY / Baltimore, MD Healthcare Investment Banking Analyst, 2008-2011 Ranked in the top quartile of analyst class. Analyzed companies using comparable company, precedent transaction, leveraged buyout, and discounted cash flow analyses. ed senior bankers in the procurement and execution of three M&A transactions, eight financings that raised in excess of $1B in equity and debt capital and one valuation assignment.

9

Kelly C. Cheng

Cyndi U. Chung

Katherine A.A. Clark

[email protected] Haverford College, Haverford, PA B.S., Honors, Chemistry, B.S., Mathematics, 2009 Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA M.D. Candidate 2015

An entrepreneurial opportunity to address healthcare challenges via technology innovations.

The integration of my science and business backgrounds to make health care more accessible and affordable for patients.

An opportunity to apply my clinical, business, and research experiences to a strategic role in medical device innovation.

McKinsey & Co., Palo Alto, CA Summer Associate 2014 Managed the transformation of clinical trial operations for a global pharmaceutical company. Oversaw several workstreams that planned and monitored outsourcing to a contract research organization.

Becton Dickinson, Franklin Lakes, NJ Strategic Innovation Intern, Medical-Surgical Systems, Summer 2014  Developed a business opportunity strategy in medical oncology to identify unmet clinical needs and managed a direct report with full-time dedication to my project.

Perelman School of Medicine, Philadelphia, PA Graduate Student Researcher, 2010-2014 Conducted analyses on risk factors for and outcomes after mandibular distraction osteogenesis, autologous breast reconstruction, and hernia repair, among other procedures.

Children’s Hospital of Philadelphia, Philadelphia, PA Medical Student Researcher, Cardiology, 2012-2013 Studied implanted medical devices modified to inhibit pro-inflammatory events. Selected for a presentation at the Scientific Sessions of the American Heart Association. Published manuscript in Biomaterials.

Augmedix, San Francisco, CA MBA Intern, Summer 2014 Developed new platform strategy by engaging strategic hardware, software, content, and services partners. Initiated development in Philadelphia metro region by pitching to 20+ health system CEOs, CIOs, CMIOs, etc. Designed and implemented hiring processes for 20+ engineering, operations, sales, and legal roles, doubling size of SF HQ. Practice Fusion, San Francisco, CA Business Development Intern, Summer 2013 Sized revenue opportunity for new data analytics business line at $15M in near-term business, projected to grow to $200M+. Designed and tested analytics prototypes with 35+ external health IT, life sciences, and health provider executives. Deloitte Consulting, San Francisco, CA Consultant 2011-2013 Business Analyst 2009-2011 Strategy consultant for clients in provider, plan, life sciences, telematics, software, and consumer products industries. Assessed t venture for integrated delivery network to develop artificial intelligence product with $107B global technology leader. Managed partnership development with $1.4B voice recognition company. Modeled post-Health Reform market changes to determine future areas of growth for $8B US health plan. Used deliverables to co-develop a Health Reform Market Offering.

10

Hospital of the University of Pennsylvania, Philadelphia, PA Medical Student Researcher, Critical Care, 2012-2013 Conducted interviews and synthesized clinician surveys of a clinical decision tool for sepsis. Refined system to result in a more sensitive alert. Selected for an oral presentation at the Mid-Atlantic Healthcare Bioinformatics Symposium. Hospital of the University of Pennsylvania, Philadelphia, PA Medical Student Researcher, Interventional Radiology, 2010 Conducted clinical research on Hereditary Hemorrhagic Telangiectasia and central venous access devices. Selected for two presentations at European IR Society Conference. Published manuscript in the American Journal of Cardiology.

Michael J. Cromwell, IV

Nicholas Y. Crowne

Jennifer A. Dikan

[email protected]  Tufts University, Medford, MA  B.S., Biomedical Engineering, 2008 Brown University, Providence, RI M.S., Engineering, 2009

An opportunity to build leading healthcare businesses through investment or management.

An opportunity to identify, build, and transform market-leading companies.

An opportunity to apply my crossdisciplinary background in engineering and business in a strategic role focused on developing innovative care models and disruptive innovations.

Castlight Health, San Francisco, CA Strategy Intern, Summer 2014 Analyzed 17 adjacent categories to inform buy/build/partner decisionmaking for newly public healthcare technology company. Performed research on third-party industry to identify disruptive growth opportunities, and presented findings directly to CFO. Developed mergers and acquisitions template to serve as valuation screening tool. Ascension Health Care Network, New York, NY Director of Financial Planning and Analysis, 2012-2013 Directed due diligence processes for prospective hospital acquisitions with Oak Hill professionals, Ascension Health subject matter experts, and outside consultants. Created multi-hospital leveraged buy-out model to evaluate hospital consolidation opportunity with combined revenues of $1B+. Oak Hill Capital Management, New York, NY Private Equity Associate, 2010-2012 Performed due diligence, created financial models and assisted portfolio company managers for private equity firm with $3.8B in latest fund. Executed transactions in home health (AccentCare), radiation oncology (Vantage Oncology), and hospital (Ascension Health Care Network) sectors. Barclays Capital / Lehman Brothers, New York, NY Healthcare M&A Analyst, 2008-2010 Executed financial models to assess M&A transactions and capital structure alternatives.

Mount Kellett Capital Management, New York, NY Summer Associate, Summer 2014 Sourced, diligenced, and presented public and private equity and credit opportunities across healthcare, TMT, business services, and financial institutions. Led research process, including analysis of unit economics, structural growth/decline, and investment catalysts to formulate investment theses and assess risk/reward. GTCR, Chicago, IL Associate, 2010-2013 Originated and led $2B of private equity transactions in healthcare sector across 3 platforms, including top-performing investment in Fund IX (Actient Pharmaceuticals), GTCR’s first life sciences investment (Cord Blood Registry), and largest healthcare equity investment (Sterigenics). Identified attractive segments within healthcare sector, analyzed market attributes, constructed detailed financial models, orchestrated due diligence efforts, and participated in board meetings. Executed five proprietary acquisitions in 24 months to build Actient Pharmaceuticals from management start-up to successful sale ($645M). Partnered with management team to acquire Cord Blood Registry and worked alongside CEO to evaluate strategic initiatives.

McKinsey & Co., Palo Alto, CA Summer Associate, Summer 2014 Developed analytic models and recommended an investment plan for improving women’s health as a part of the strategy for a global health foundation. Natera, San Carlos, CA Product Manager, 2009-2013 One of the first employees at Natera, a diagnostics company focused on improving maternal and fetal health through genetic insights. Led crossfunctional decision-making across engineering, marketing, and sales to develop a suite of prenatal genetic testing products. Managed workflows across a team of 12 to ensure products and strategy were executed effectively and within executive management and board expectations. Took insights from the field through sales calls, conference meetings, and grand rounds presentations to inform product strategy and align priorities across teams.  

Moelis & Company, New York, NY Analyst, Mergers & Acquisitions, 2009-2010 Merrill Lynch & Co., New York, NY Analyst, Media & Telecom Investment Banking Group, 2008-2009

11

Dean L. Drizin

Christine Du

[email protected] University of California, Los Angeles, CA B.S., Biochemistry, 2007 Columbia University, New York, NY M.A., Biotechnology, 2010

An opportunity to leverage my combined skill set in medicine and management to improve health care delivery and patient outcomes.

An opportunity in a strategic or consulting role focusing on health care.

University of Colorado, Department of Medicine, Aurora, CO Co-Investigator, Summer 2014-Present Implementing system changes via a multi-disciplinary, multi-hospital quality improvement initiative to improve the patient care handoff process. United States Navy, Bethesda, MD ENS, MC, USNR, 2011-Present Medical education funded by the United States Navy Health Professions Scholarship Program (HPSP). Upon graduation, will serve as an active duty physician in the United States Navy. KBL Healthcare, New York, NY Associate, 2007-2009 Sourced and evaluated potential transactions; communicated with senior management of prospective acquisitions; developed financial models; drafted letters of intent; prepared company and investor presentations; assisted in management of portfolio companies of KBL Healthcare Ventures Banc of America Securities, New York, NY Investment Banking Analyst, Healthcare Group, 2005-2007 Conducted qualitative and quantitative financial analyses for the healthcare services, medical technologies, and life sciences sectors for M&A, IPO, and capital raisings. Developed in-depth quantitative modeling and transaction experience.

12

Janssen Biotech Inc., Horsham, PA Experience Commercial Leadership Program Intern, Summer 2014 Built and piloted specialty pharmacy provider (SPP) performance dashboards for 3 brands: Simponi UC, Stelara, and Zytiga. Developed and identified leverage points along the patient fulfillment process for oncology and immunology strategic imperatives by working with 4 external partners, 50 key stakeholders spread across 10 business units within Janssen. Corum Inc., Taipei Taiwan Sr. Marketing Executive, 2012-2013 Marketing Executive, 2010-2012 Spearheaded the company’s strategic plans, client management, legal processes, technical investments; set global marketing strategy/product positioning and segmentations, increased company profits by 400x in 2 years. Initiated and oversaw new sales channels and new product indications in North America, EU, Latin America, China and Japan, ultimately leading to an over 20x increase in US sales revenues in 2012. Developed international business opportunities in 25 countries and planned 50+ product launches through global partnerships. Trained, reviewed, and ed 15 field sales reps and 30 distribution companies worldwide to establish 15 new Fortune 500 s, including L’Oreal, Unilever, and Limited Brands in one year.

David C. Fajgenbaum, M.D. [email protected] Georgetown University, Washington, DC B.S., Magna Cum Laude, with Distinction, Human Sciences, 2007 Oxford University, Oxford, UK M.Sc., Public Health, 2008 Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA M.D., 2013 An opportunity to apply my clinical, research and business experiences to accelerate drug development for diseases with significant unmet needs. Bristol-Myers Squibb, Plainsboro, NJ Medical Strategy Intern, Summer 2014 Led initiative to identify data gaps and design strategic projects for company’s highest-selling oncology drug ($1.4B in 2013). Developed comprehensive plan to overcome insurer restrictions to oncology drugs. Identified a risk to immuno-oncology field and proposed risk-mitigation solutions. Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA Adjunct Assistant Professor of Medicine, 2014-Present Member, Center for Orphan Disease Research/Therapy, 2013-Present Appointed faculty member in Division of Hematology/Oncology to conduct clinical research and lead an international study as Principal Investigator. Castleman Disease Collaborative Network, Philadelphia, PA Co-Founder & Executive Director, 2012-Present Launched global initiative to accelerate drug development for Castleman disease. Published research that caused a paradigm shift in the model of pathogenesis. Established $4.5M partnership with Janssen Pharmaceuticals to build a first-of-its-kind registry/ natural history study. Direct 12-member team and 23-member International Scientific Advisory Board.

Zoe C. Farrell

Danika M. Fry

Jennifer L. Funk

[email protected] Georgetown University, Washington, DC B.S.B.A., Summa Cum Laude, ing, 2008

An opportunity to build successful healthcare businesses through growth equity investment and effective management.

An opportunity to advance health care innovation through effective investment and strategic advisory.

An opportunity to work on a dynamic team within health care services, with responsibility for both clinical operations and near-term strategy.

Apple Tree Partners, Princeton, NJ / New York, NY Summer Associate, Summer 2014 Performed due diligence for two investments that closed in Aug/Sep 2014 as part of the firm’s $1.67B fund: Series A in the opioid treatment space and Series B in the care coordination space. Developed healthcare IT investment thesis based on extensive literature and field research. Worked with an entrepreneur-in-residence in the planning stages of a population health management start-up. Marwood Group, New York, NY Associate, 2013 Analyst, 2011-2012 Performed due diligence for private equity clients making healthcare investments. Advised on commercial / government payor reimbursement environments, legislative trends, and Medicare / Medicaid policy changes. Conducted primary and secondary market research for 100+ projects in numerous healthcare subsectors. Boston Children’s Hospital, Boston, MA Genetics Researcher, 2009-2010 Conducted genetics research to understand the orphan disease of nemaline myopathy. Co-authored a paper published in a highly regarded genetics journal.

Wells Fargo Securities, San Francisco, CA Summer Associate, Healthcare Investment Banking, Summer 2014 Provided M&A advisory to specialty pharmaceutical, medical device, and biotechnology companies. Developed marketing materials, conducted diligence, developed presentation materials, and provided process updates to client during a sell-side divesture. Worked with a biotechnology company’s C-suite to perform diligence for a private placement, and draft S-1 for confidential IPO filing. Performed valuation analyses using public comparables, precedent transactions, and DCF. Accenture, San Francisco, CA Consultant, 2010-2013; Analyst, 2007-2009 Advised healthcare, pension, and technology firms on organization design, training needs, and communication development. Select engagements:  1) created a project plan to drive reorganization of Biomedical Technology and Philanthropy business units for a 29-hospital system. Negotiated biomed union contracts and directed relevant meetings with site management, hospital istration, and HR. Convinced 10 separate foundations to transfer funds to a consolidated to achieve financial and managerial efficiencies; 2) engaged client executives across multiple business units to gain buy-in for an organization change strategy; 3) managed crossborder team to develop and deliver training courses to internal and external stakeholders of a public pension fund.

DaVita Healthcare Partners, Denver, CO Redwoods Summer Associate, Summer 2014 Led a project exploring upstream patient education opportunities within hospitals. Determined how new kidney patients are educated today on their choices while in the hospital, through extensive secondary research and a dozen hospital visits across the country. Designed two in-hospital patient education programs that are now being piloted. The Bridgespan Group, Boston, MA Consultant, 2012-2013 Senior Associate Consultant, 2011 Strategy consultant for non-profit clients, with a focus on public health. Worked with several public health foundations to define their five-year investment strategy at the enterprise and initiative levels. Mentored and managed two junior teammates and was recognized as a finalist for officewide “Coach of the Year” award. Bain & Company, Chicago, IL Senior Associate Consultant, 2010-2011 Associate Consultant, 2008-2010 Strategy consultant across sectors, with healthcare clients in hospital services, pharmaceuticals, and claims istration. Project examples include cardiac service line and outpatient expansion strategies, merger integration, and process redesign for financial forecasting.

13

Jin Ge

Daniel E. Geoffrion

Jeffrey S. Goodman

[email protected] Harvard University, Cambridge MA A.B., Cum Laude, Economics, 2009

An opportunity to combine my clinical and business experiences to transform care delivery to improve quality and outcomes.

An opportunity to apply my strategy experience to an operational role that gives patients access to quality services and/or devices.

An opportunity to help lower middlemarket healthcare services companies develop into industry leaders.

Kaiser Permanente, Oakland, CA Performance Excellence Intern, Summer 2014 Developed metrics to measure end-oflife quality at KPNC hospice agencies. Conducted chart reviews and analyzed variations in cost and outcomes at KPNC medical centers to develop clinical best practices.

Medtronic, Minneapolis, MN Corporate Strategy Summer Associate, Summer 2014 Developed growth strategy for Integrated Health Solutions to quintuple revenue by 2018. Conducted deep dives in 6 European countries to understand how patients and money flow through each healthcare system in order to best position and communicate value of Medtronic’s solutions portfolio.

Becton-Dickinson Diagnostics, Franklin Lakes, NJ Strategy and Development Intern, Summer 2014 Researched innovation thesis to serve the biobanking industry. Modeled costs, value creation potentials, and revenue potentials for major players in the sector. AirCare, Philadelphia, PA Business Associate, 2013-2014 Assisted in fundraising activities for AirCare, a health IT startup focused on developing a communications and remote monitoring platform to reduce hospital reissions for patients with CHF. The Boston Consulting Group, New York, NY Senior Associate Consultant, 2008-2010 Developed a brand revitalization plan for a biopharma in the nutritional space. Identified cost-savings opportunities in the post-merger integration of preclinical and PK/PD units of two biopharmas. Evaluated new product launch plans for a med-tech company, calculated an economic impact of $400M.

14

Boston Consulting Group, Detroit, MI Associate, 2010-2013 Enabled executives to solve key strategic issues. Projects led to the initiation of a hospital system merger ($7B combined revenue), sale of an auto supplier business unit ($500M revenue), consolidation of 31 equity portfolios ($40B AUM), and delayering ($20M savings) of a consumer goods company. Responsibilities included creating models, evaluating potential targets, market sizing, deg decision trees, developing strategic rationale, and communicating with executives.

athenahealth, Watertown, MA Business Development Intern, Summer 2014 Identified, researched, and assessed 200+ prospective healthcare technology partnerships/acquisitions as part of athena’s strategy to build out its inpatient revenue cycle and clinical software solutions. Met with management teams of 35 companies to evaluate their best-of-breed technology-enabled services. Presented analysis and recommendations on how select partnerships may athena’s effort to address key hospital pain points. Waud Capital Partners, Chicago, IL Associate, 2011-2013 Evaluated and assessed control-oriented growth equity investment opportunities in healthcare, business, and consumer services out of the firm’s $463M Fund III. Collaborated with team of investment professionals to close one platform investment, five add-on acquisitions, and two portfolio company debt financings. Partnered with management teams of portfolio companies to create business strategy, assess and structure strategic acquisitions, access financing sources and develop corporate governance as a board observer. Bank of America Merrill Lynch, New York, NY Analyst, Mergers & Acquisitions Group, 2009-2011 Contributed to client acquisition strategy through financial analysis, valuation assessment, and company due diligence, resulting in four closed transactions.

Seema A. Gunda

Jonathan D. Hahn 

Miles Hammond

[email protected] University of Pennsylvania, Philadelphia, PA B.A., History, 2007

An opportunity to improve patient care through life sciences strategy.   Genzyme, A Sanofi Company, Cambridge, MA Business Development Intern, Summer 2014 Led initiative to define Genzyme’s investment strategy in Multiple Sclerosis symptoms by prioritizing conditions and conducting a
comprehensive asset scan. Collaborated with R&D, Medical Affairs, Commercial Operations, and Market Access. Approach to be leveraged in multiple business units.

An opportunity to build, grow, and improve health care through strategy or operations.

An investing role with exposure to health care.

Leerink Swann, New York, NY Consulting Associate, 2011-2013 Consulting Analyst, 2009-2011 Strategy consultant for pharmaceutical, biotechnology, medical device, and financial clients with life sciences assets. Experience includes creating a loss of exclusivity strategy for a global pharma client. Built complex modeling tool to assess economic impact of various pricing scenarios on key s, resulting in ~10% revenue increase. Managed a team of five on a group-wide initiative to improve efficiency and overall experience of consulting group. Sanford C. Bernstein, New York, NY Research Associate, Summer 2008 Authored 35-page report on value of high-end consumer care products relative to low-end substitutes and impact on sector leaders during recession. This report was distributed to 200+ clients and presented in firm-wide meeting.

athenahealth, Watertown, MA Analytics Strategy Intern, Summer 2014  Assessed athena’s analytics strategy for large enterprise clients and reviewed internal and external capabilities to meet anticipated demand. Built proof-of-concept reporting product, piloted prototype to hospital executives, and created roap for late 2014 implementation. Conducted client interviews, identified potential customer segments, and created internal sales message. Amundsen Group – an IMS Health Company, Burlington, MA Senior Associate Consultant, 2012-2013 Associate Consultant, 2010-2012 Advised top 10 pharmaceutical companies on more than 15 projects focused on market access, marketing strategy, and pricing/reimbursement issues. Responsibilities ranged from client management to project management to heavy data analysis and modeling. Managed implementation of novel analytics process and led communication across multiple business units, tech divisions, and external vendors for multi-billion dollar respiratory portfolio. Analyzed marketing strategy and recommended initiatives focused on patient acquisition. Created new hire training program, led case simulations, and streamlined onboarding process for new hires, leading to a two-thirds reduction in training time.

Glenhill Capital, New York, NY Summer Research Analyst, Summer 2013 Identified and analyzed long/short equity investments in healthcare, industrials, and telecom at a bottomup fundamental long/short equity hedge fund with $1.6B AUM. Worked directly with Head of Research to execute and monitor 4 investments during 12-week internship. Enhanced Equity Funds, New York, NY Private Equity Associate, 2010-2013 Contributed to all aspects of investment process at a healthcare private equity firm with $600M under management, which invests in lower middle market healthcare services companies. Participated in 15 transactions across 4 platforms and served on the Board of Primary Care Associates, a chain of primary care clinics acquired in 2012. Barclays, New York, NY Health Care Investment Banking Analyst, 2008-2010 Covered companies across life sciences, healthcare services, and managed care. Contributed to several closed transactions, including Sole M&A advisory on Abbott’s acquisition of Solvay pharma for 4.5B in 2012. Ranked in top bucket during three out of four review cycles.

15

Elizabeth C. Hansen

Andrew D. Hedin

Roberto L. Hernandez

[email protected] University of Florida, Gainesville, FL B.S., Cum Laude, Computer & Electrical Engineering, 2007

A direct investing opportunity with exposure to the healthcare sector.

An opportunity to operate and invest in innovative health care companies through venture capital or private equity.

An opportunity to solve challenging financial, operational and strategy problems within health care.

Health Essentials LLC, Santa Ana, CA MBA Operations Intern, Summer 2014 Worked directly with the management team of the healthcare services venturebacked company. Collaborated with clinical, operations, IT, and finance as a project manager to launch dual eligible coordinated care product. Assessed population health software vendors and led RFP process.

Bank of America Merrill Lynch, Palo Alto, CA Summer Associate, Technology Investment Banking, Summer 2014 Provided M&A Advisory for technology companies. Analyzed strategic acquisitions opportunities including redomiciling targets. Managed buy-side process and developed management presentations for a leading financial technology firm. Performed accretion/ dilution and valuation analysis using public company comparables, precedent transactions, LBO, and discounted cash flow.

Putnam Investments, Boston, MA Equity Research Intern, Summer 2014 Conducted fundamental due diligence on public and private healthcare IT companies through product demonstrations, attending industry conferences, HQ visits, hosting company meetings, and expert calls; developed market and company models. Clarion Healthcare, LLC, Boston, MA Consultant, 2013-2014 Associate, 2010-2013 Advised a wide range of clients from biotechs to multinational pharmaceutical companies, contract sales organizations, medical device companies, and private equity and venture capital investors. Project work included due diligence / strategic transaction (for manufacturers’ BD/New Products groups and PE/VC investors), sales force strategy and implementation, marketing innovation recommendations, and managed care strategy. Focused extensively on the quality of care incentives that providers are facing as a result of healthcare reform and their implications for healthcare manufacturers and investors.

Fidelity Biosciences, Cambridge, MA Senior Analyst, 2012-2013 Analyst, 2010-2012 Executed 16 new investments and 9 follow-on investments in biotech, medical device, healthcare IT, and healthcare services companies for a venture capital fund with $1B under management. Led strategic, technical, regulatory, market, and financial due diligence efforts. Invested in private startup companies (Series A – Series D) focused on healthcare IT, ultra-rare diseases, novel technologies in emerging markets, specialty hospitals, cancer, ophthalmology, dermatology, and hospital equipment. Served as board observer for two portfolio companies. Leerink Partners, Boston, MA Associate, 2009-2010 Analyst, 2007-2009 Advised life sciences clients in over 20 consulting engagements in clinical development strategy, commercial opportunity assessments, M&A strategy, product life cycle management, and competitive landscape analysis.

16

Harris Corporation, Washington, DC Project Manager, Dept. of Veterans Affairs, Veterans Health Benefit Enrollment Innovation Project, 2013 Reduced delays in the enrollment and processing of veterans’ health benefits by deg, testing and deploying improved software tools. Achieved 15.3% ROS, exceeding management’s expectation of 12%, by effectively managing an 8 member team of analysts, software developers, and test engineers. Business Development Manager, Healthcare Solutions Team, 2010-2013 Built and fostered my organization’s relationship with the US Coast Guard’s Medical Division and guided that relationship to an $11M contract award to provide our EMR installation and maintenance services. Engineered the technical specifications and features of a cloud-based electronic health record solution as a member of a multi-disciplinary team of engineers and medical specialists.

Luis M. Jones

Ford Kerr

Michael J. Kramarz

[email protected] Duke University, Durham, NC B.S.E., Summa Cum Laude, Phi Beta Kappa, Biomedical Engineering, 2010 Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA M.D. Candidate, Alpha Omega Alpha, 2015

An opportunity to solve challenging problems in the health care industry.

An opportunity requiring entrepreneurial and strategic thinking within the context of mobile health, companion diagnostics, or other disruptive forces with potential to make a significant impact on the health care industry.

An opportunity to build leading health care companies using my expertise in medicine and business.

McKinsey & Company, Atlanta, GA Summer Associate, Summer 2014 Managed materials workstream on healthcare project that involved creating and monitoring a war room, tracking key process metrics, and implementing process improvements in order to assist the client in meeting critical product delivery dates. Medtronic Spinal & Biologics, Memphis, TN Senior Product Development Engineer, 2010-2013 Designed and developed innovative instruments to facilitate the insertion of spinal implants by collecting and analyzing from surgeons. Led cross-functional team on strategic projects to develop custom implants in order to improve the lives of patients and convince competitive surgeons to adopt Medtronic products. Completed the Medtronic Emerging Leader Program (participants are chosen through a rigorous selection process that identifies high performing employees). Covidien Neurovascular, Irvine, CA Quality Engineering Team Lead, 2008-2010 Managed team of engineers and technicians that provided focused quality on micro catheters production lines. Implemented process improvements through the execution and timely closure of nonconformance reports, maintenance and analysis of statistical process control charts, and completion of process validations on new equipment and fixtures.

Fitly, Philadelphia, PA Co-Founder and CFO, Summer 2013-Present Developed launch strategy, raised $210,000 in seed funding, established strategic partnerships, and launched the company. Designed/implemented supplier operating model in 2 stores in 2 months, establishing a delivery radius across 68 zip codes. Awarded ission into 3 competitive startup accelerator programs and won the Wharton Venture Award. Booz & Company, Washington, DC Senior Consultant, 2013 Consultant, 2011-2012 Strategy consultant for pharmaceutical, biotechnology, and payer clients with project experience in strategic launch planning, strategic capability assessment and design, companion diagnostics strategy, pipeline asset evaluation, post-merger integration, and commercial opportunity assessments in the digital/mobile health space. Entre Todos (Microfinance Company), Buenos Aires, Argentina Loan Officer, Internal Consultant, 2009-2010 Worked as a loan officer with a portfolio of 70+ clients, developed/implemented client training programs to teach foundational business skills, and co-led the 6-month restructuring of a private microfinance firm.

Celgene Corporation, Warren, NJ Strategy Intern, Summer 2014 Worked in a strategy role within Celgene Cellular Therapeutics (CCT), a wholly owned subsidiary of Celgene Corporation. Constructed long-range plan for Organ & Tissue Therapeutics division. Assessed next-generation opportunities for placental-derived regenerative medicine platform. Analyzed specific growth strategy for CCT’s umbilical cord blood bank, LifebankUSA. HealthpointCapital, New York, NY Intern, Summer 2013 Performed clinical due diligence for $35M acquisition target, assessing technology’s efficacy and indications. Analyzed the competitive landscape, detailing competitors’ products, pricing, and market positions. Developed materials for and participated in Scientific Advisory Committee meeting regarding the acquisition. Children’s Hospital of Philadelphia, Philadelphia, PA Research Fellow, Summer 2011 Conducted clinical research in the Department of Neurosurgery resulting in poster presentation at annual American Association of Neurological Surgeons meeting and publication in Neurosurgery. Authored three textbook chapters on pediatric neurosurgical topics published in Pediatric Cancer, Spine Surgery Basics, and Neurosurgical Post-Operative Monitoring and Complications.

17

Lindsay E.Y. Kuo, M.D. [email protected] Massachusetts Institute of Technology, Cambridge, MA B.S., Biology, B.S., Literature, 2006 Northwestern University Feinberg School of Medicine, Chicago, IL M.D., 2010

An opportunity to apply clinical and business knowledge to advance the quality of care patients receive. Center for Surgery and Health Economics, Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA Research Fellow, July 2013-Present Performed outcomes research, primarily focused on endocrine surgery, and health services research. Received a research grant from the Society of American Gastrointestinal and Endoscopic Surgeons. Presented at national meetings. Multiple publications published in peer-reviewed journals. Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA Resident in General Surgery, 2010-Present Responsible for all aspects of pre-, intra- and post-operative care. Currently at the post-graduate year 5 level. Responsibilities include operating, daily patient care decision-making, and communicating with patients/ families. Responsible for leading the inpatient care team, including multiple junior residents and mid-level providers. Experienced in surgical critical care and cardiovascular surgical critical care. Experienced in diagnosis and treatment of vascular, thoracic, endocrine and oncologic, bariatric, colorectal, minimally invasive, trauma, and general abdominal surgery. Responsible for medical student teaching integrated into all aspects of clinical surgery.

18

Jonathan M. Lanznar

Christina S. Liao

[email protected]  Massachusetts Institute of Technology, Cambridge, MA S.B., Brain and Cognitive Sciences, 2008

An opportunity in strategy and business development at a growth stage healthcare services or technology company.

An opportunity to improve the quality, efficiency, and experience of patient care at an integrated health system.

Quantia Inc., Waltham, MA Strategy and Business Development Associate, Summer 2014 Developed the go-to-market strategy for a new product targeting high-value medical technology companies and managed the initial sales team rollout. Created models to project the market size and value of additional physician ; presented to executive team and insights incorporated into fundraising strategy. Executed a segmentation of clients and identified opportunities to reprioritize sales, marketing and partnership targets.

Cedars-Sinai Health System, Los Angeles, CA MBA Intern, Clinical Transformation, Summer 2014 Led 15-member cross-disciplinary task force in developing the strategy and tactical roap for managing financial and clinical risk in new payer contracts. Designed pilot program for e-visits and presented recommendations to Medical and Clinical Directors to gain operational buy-in.

InterbrandHealth, New York, NY Senior Consultant, 2013 Consultant, 2011-2013 Associate Consultant, 2008-2011 Managed brand development programs with cross-functional teams for 15+ clients across the healthcare industry. Programs ranged from product launches to mergers and acquisitions. Example projects include: creating the integration strategy for the merger of two medical device companies, coordinating the rollout of a new strategy for a diagnostic services company while growing the from $600,000 to $2M, and consolidating a headache market segmentation to identify core prime prospects to achieve an $18M yearly growth target.

Monitor Group, Los Angeles, CA Senior Consultant, Life Sciences, 2011-2013 Consultant, Life Sciences, 2010-2011 Advised top 10 pharmaceutical, biotechnology, and medical device clients on marketing and organizational strategies. Developed various product positioning, segmentation, and physician messaging strategies for pre-launch and in-line products. Designed and launched a global Center of Excellence in access and reimbursement for a $15B biotechnology firm. The Walt Disney Company, Burbank, CA Financial Analyst, Business Planning & Development for Parks & Resorts, 2008-2010 Conducted financial modeling and due diligence research on potential acquisition targets in the travel and leisure sector. Led market sizing, profitability benchmarking analysis, and consumer segmentation for annual business line reviews with more than 20 finance and operations leaders.

David E. Light

Ethan I. Lipkind, J.D.

Patricia J. Liu

[email protected] University of Pennsylvania, Philadelphia, PA B.S., Magna Cum Laude, Management & Operations Management, 2010

An opportunity to grow a company in the wellness, nutrition or biopharmaceutical sectors through a direct investing, strategy or operations role.

An opportunity to create value for healthcare businesses through private equity investing or strategy role. Cressey and Co., Chicago, IL Summer Associate, Summer 2014 Engaged in all aspects of healthcare services investment processes including due diligence, modeling, and financing. Advised investment committee on healthcare services trends and sector opportunities, leading to 2 new investment theses.

An opportunity to pursue strategy and marketing to impact consumer health and nutrition within the retail sector.

Biogen Idec, Cambridge, MA New Product Commercialization Intern, Summer 2014 As a member of the launch strategy team for an asset in Phase III, led a project to develop a strategy and identify tactics to improve the efficiency of diagnosis of a rare, neuromuscular condition. Worked with cross-functional internal partners, sourced and managed external consultants, conducted primary research, and presented recommendations directly to division Vice President. Putnam Associates, Burlington, MA Senior Consultant, 2012-2013 Analyst, Associate, Senior Associate, Consultant, 2008-2012 Led strategic consulting projects for six top 15 pharmaceutical companies, and three top 10 biotechnology companies. Areas of project focus include oncology, hematology, neurology, infectious disease, and health IT. Project responsibilities included creation of detailed forecast models, patient and physician strategic segmentation for marketing activities, design of payer contract , recommendation on tactics for engagement with patient advocacy, structuring pharmaceutical distribution contracts, and recommendations on clinical development plans. As a manager, trained, developed, and oversaw 30+ junior team (~ 4-5 per project). Merck & Co., Rahway, NJ Associate Chemist, 2007-2008 Designed and synthesized over 100 novel small-molecule drug candidates based on structure-activity data and spectroscopic analyses. Contributed to patents for two drug candidate scaffolds.

Complete Healthcare Management, Chicago, IL Principal, 2011-2014 Provide legal, compliance, and management services to physician practices and hospitals; sample transaction: formed multi-specialty group by merging neurosurgery and interventional radiology physician practices and launched stand-alone diagnostic medical imaging center to capture revenues from new group’s referrals. Michigan Rural Healthcare Preservation Holding Co., d/b/a Michigan Clinic, Chicago, IL and MI CEO, Director, 2009-2013 Managed over 400 employees. Oversaw operations and growth of health care provider holding company; responsible for all investment and corporate development decisions. Sourced, financed, structured, and executed acquisition of 2 community hospitals. Organized network affiliations with multiple physician practices, a research institute, and a medical school. Turned around hospital from perennial operating losses to highest net patient revenues and earnings in its 60-year history; doubled hospital assets, increased operating revenues 154%, decreased liabilities 45%.

Walmart eCommerce, San Bruno, CA @WalmartLabs Mobile Strategy Intern, Summer 2014 Evaluated mobile trends and features for Walmart to prioritize going forward. Assessed iPad app performance across the business portfolio to identify strengths and pain-points. Hosted business development meetings with entrepreneurs interested in partnering with Walmart in the mobile technology space. Conducted research across competitor mobile grocery apps to understand desired functionality in preparation for the Walmart To Go (grocery delivery) app launch.   Deloitte Consulting, New York, NY Consultant, 2010-2013 Provided strategic and managerial guidance for companies across both the health care and retail industries, with project work focused on customer and market insights. Sample projects: 1) performing a deep-dive on stakeholder influencers to improve provider targeting and segmentation for a pharmaceutical company; 2) enabling international growth initiatives by reprioritizing budget allocations and discretionary spend for a medical device company 3) analyzing consumer purchase habits and marketing effectiveness for an ecommerce retailer; 4) developing a predictive scorecard to enable store expansion for a global retailer.

19

Wei (Lluvy) Liu

Sofya Lyashko

Duncan Mackay

[email protected] Duke University, Durham, NC B.S., Cum Laude, Neuroscience and Psychology, 2007 Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA M.D. Candidate 2015

An opportunity in management consulting or international business development focused in healthcare.

An opportunity in pharma/biotech strategy analysis or health care consulting.

An opportunity to integrate my medical and business expertise to improve design of health care delivery systems.

The Boston Consulting Group, Shanghai, China Summer Consultant, 2014 Co-developed subsidiary role classification system and management guidelines for the governance of overseas subsidiaries for a leading global ICT solutions provider head quartered in China. Conducted benchmark study on foreign subsidiary management of 4 global technology conglomerates, presented findings to the head of Investment Management Department, and received high remarks.

McKinsey & Company, Moscow, Russia Associate, Summer 2014 Worked with a client team to run analysis and develop opportunities to increase revenues.

University of Pennsylvania Health System, Philadelphia, PA; University of Pittsburgh Medical Center, Pittsburgh, PA Sub-Internships in Plastic Surgery, Summer 2014 Acting intern on plastic surgery service, treating patients, assisting in surgery across the spectrum of the plastic surgical field, including general reconstructive surgery, trauma reconstruction, breast reconstruction, craniofacial surgery, cosmetic surgery, and hand surgery. Active in clinical and basic science research.

B.Braun Medical, Beijing, China Key Supervisor, 2012 Senior Sales, 2010-2011 Developed sales strategies to increase market penetration, doubling sales revenue and market share of previous year. Designed key management model to optimize resource allocation and created performance improvement initiatives to enhance sales team productivity. Received full score in annual performance evaluation with fast-track promotion and awarded “Best Sales”, “Early Bird”, “Key Management Champion”, and “Excellent New Employee”. Johnson & Johnson Medical, Beijing, China Sales Management Trainee, 2009-2010 Managed sales at the largest cardiovascular hospital key in China. Established strategic partnership with industry key opinion leaders and enhanced clients’ clinical expertise with physician education programs. Awarded “Best Project Execution”.

20

TMK, Moscow, Russia Head of Financial and Economic Analysis Department, 2011-2013 Led a team of analysts to perform analysis of economic and operational performance of the company with a $7B revenue for the needs of investors and management. Built valuation model for a company’s acquisition. Developed and implemented plan for a pre-acquisition debt restructuring. Ernst & Young, Moscow, Russia Manager, 2005-2011 Led a team of auditors focused on serving pharmaceutical companies and healthcare providers. Awarded as a manager of the best audit project in 2010. Achieved 25% reduction in the project time and 60% growth in the project’s profitability. Designed audit procedures that were included in the monthly emails distribution as best practices examples. Was elected by the company’s senior management to the board of experts.

Friends of NOAH, USA, Hershey, PA Co-founder, Director 2009-Present Friends of NOAH USA, (Nurturing Orphans of AIDS for Humanity), is a grassroots nonprofit designed to help communities raise their orphaned children by providing physical, educational, and psychosocial to the extended family network of children in South Africa who have been orphaned by AIDS. Co-ran the organization, built and ran online presence, organized annual fundraisers, researched and assessed our practices and outcomes. To date, we have raised over $120,000 and care for over 250 children.   Bain & Company, Chicago, IL Associate Consultant, 2007-2009 As a strategy consultant, structured and performed analyses that drove impactful recommendations for Fortune 500 clients. Built financial models, assessed and recommended M&A targets, developed research tools, assessed and implemented executive culture and communication improvements.

Amit A. Mahadevia [email protected] Yale University, New Haven, CT B.A., Psychology / Behavioral Neuroscience, 2008

Kristen E. Manderscheid [email protected] Duke University, Durham, NC B.S., Magna Cum Laude, Economics, 2010

Carlo Martelossi [email protected] Bocconi University, Milan, Italy B.B.A., M.S., Finance, 2011

An opportunity in strategy or business development at a biotech or pharmaceutical company.

An opportunity to develop and refine global pricing and market access strategies for select pipeline assets.

An opportunity to make an impact and create value through operational improvements.

Celgene Corporation, Summit, NJ Global Marketing Intern, Summer 2014 Designed and executed an NPV analysis to assess commercial value of an internal asset and biomarker strategy in a large lymphoma indication. Worked closely with clinical team to design clinical trial scenarios to development of asset. Analyzed development opportunity of a pipeline asset in a niche lymphoma indication not currently addressed, including review of treatment process and competitive landscape, and recommendation of how to optimize value of the asset. Created global messaging platform based on results of a randomized clinical trial and collaborated with US and global marketing leadership to validate and deliver messages.

Biogen Idec, Cambridge, MA Pricing & Reimbursement Strategy MBA Intern, Summer 2014 Led a project examining the financial and strategic impact of federally mandated 340B drug discounts on a pipeline asset, to inform U.S. launch planning. ed the P&RS group by providing pricing estimates for an early-stage pipeline asset across three targeted indications, to inform indication prioritization and global commercial forecast. Helped manage an external vendor conducting primary payer research in U.S. and , to understand value drivers and pricing potential for pipeline drug.

Zalora, Jakarta, Indonesia Marketing Intern, Summer 2014 Designed and implemented new processes for promotional campaign development and customer relationship management teams, creating new roles, clarifying responsibilities, and introducing new incentive schemes. Developed segmentation for Zalora’s 200,000 customers in Indonesia based on identified main drivers of purchasing behavior and launched pilot to evaluate the effectiveness of newsletters tailored to customer preferences.

ZS Associates, Boston, MA Consultant, 2012-2013 Associate Consultant, 2010-2012 Business Associate, 2008-2010 Sales and marketing strategy consultant for pharmaceutical, biotech, and medical device companies. Managed teams of associates in conducting qualitative and quantitative market strategy engagements. Moderated qualitative interviews with physicians (across many specialties) and patients. Designed and analyzed quantitative research instruments to inform commercial strategy.

Deloitte Consulting, Boston, MA Consultant, 2012-2013 Analyst, 2010-2012 Strategy and operations consultant focused primarily on pharmaceutical clients. Responsibilities included strategic advisement, analytical model development, process design, and project management. Major projects were: future-state design of global quality control processes within clinical trial data management; development of a U.S. brand planning tool to effectively manage marketing spend for client’s top 25 U.S. commercial drugs; and creation of business analytics to track effectiveness of a global data compliance project across 57 countries and 5 third-party vendors.

The Boston Consulting Group, Milan, Italy Associate, 2011-2013 Identified and launched strategic pricing initiatives in , , and Spain for major American medical device manufacturer as part of the redefinition of the go-to-market model leading to $25M bottom-line impact. Performed competitive analysis and quantitative assessment of the Italian Generics market in strategic due diligence on pharmaceutical company for top private equity firm. Defined new customer segmentation and targeting strategy for top European corporate and investment bank based on opportunities for crossselling of high-value-added products resulting in $50M increase in revenues. Deutsche Bank, Milan, Italy Investment Banking Intern, Fall 2010 Managed coverage activities on clients in the consumer, retail, industrial and healthcare sectors.

21

Caitlin L. McAuliffe

Lisa E. Perlmutter

Gordon I. Phillips

[email protected] Williams College, Williamstown, MA B.A., Math & Economics, 2008

An opportunity to apply my medical and business experience to improve patient quality of care.

An opportunity in strategy, operations, or business development to improve value in health care delivery.

University of Pennsylvania Health System, Philadelphia, PA Research Assistant, Department of Orthopaedic Surgery, 2011-2014 Critically examined precipitating factors for unplanned ission to the intensive care unit following arthroplasty. Spearheaded due diligence process in preparation for first published study, simultaneously laying groundwork for multiple subsequent studies, with ultimate goal of maximizing patient safety and clinical quality in t replacement surgery.

Aetna able Care Solutions, Hartford, CT Product Strategy/Market Intelligence Intern, Summer 2014 Member of team forging innovative partnerships and insurance models with providers. Developed business case and new product concept for comprehensive at-home care solution to help providers lower the total cost of care. Created due diligence model to evaluate one of Aetna’s business strategies and the viability of a new solution in three markets.

A health care finance role in banking, private equity or business development, leveraging my prior operational and strategic experience.   Raymond James, Nashville, TN Associate, Summer 2014 Led teams in the execution of multiple M&A processes, the creation of marketing materials and the underwriting of $140M in capital raises for middlemarket health care services businesses, primarily in the behavioral health and hospice industries. 

Walter Reed Army Medical Center, Washington, DC Research Assistant, Center for Neuroscience and Regenerative Medicine, 2009-2010 Investigated traumatic brain injury, spinal cord injury, phantom limb pain and other sequela of amputation. Participated in several original research projects by writing research protocols, participating in the Institutional Review Board process, and assisting with the execution of protocols.

The Advisory Board Company, Washington, DC Senior Analyst, 2012-2013 Research Analyst, 2010-2011 Completed four best-practice research studies and several web conferences for a client base of 400+ senior hospital executives. Analyzed primary and secondary research into actionable strategies for hospital executives on topics including clinical quality performance, physician engagement and contracting, physician leadership development, ICU management, and use of advanced practice providers. Developed tools to help clients implement best practice strategies, including ROI analysis of palliative care and a toolkit for improving project management skills.

Walter Reed Army Medical Center, Washington, DC Clinical Research Assistant, Physical Medicine and Rehabilitation Service, Summer 2008 Treated multiple amputee patients with experimental mirror therapy designed to reduce phantom limb pain.

22

CVS Caremark, Woonsocket, RI Senior Analyst, 2011-2013 Designed and implemented a new chain-wide service guiding patients and doctors through the process of switching from a 30- to 90-day supply of select maintenance medications, increasing prescription drug adherence by 15% for converted patients and converting over 1M patients in first 12 months of program operation. Leveraged this capability to retain Walgreens patients during the Walgreens-Express Scripts dispute. Monitor Company Group, Cambridge, MA Senior Consultant, 2008-2011 Led teams in the creation of pricing, growth, and partnership strategies for a variety of corporations across the pharmacy, insurance, and pharmaceutical industries. Examples include the creation of an econometricallyderived Medicare prescription drug plan pricing strategy for a national health insurer and prioritizing the development of pharmacogenomics revenue streams for a leading pharmacy benefits manager.

Visali V. Ramanathan

Emily T. Reid

Matthew B. Ritz

[email protected] Georgia Institute of Technology, Atlanta, GA B.S., Highest Honors, Management, 2007

An opportunity to identify and build successful life sciences companies through a business development or investing role.

An opportunity to build and grow a health technology company.

A direct investing opportunity with exposure to the healthcare sector.

Castlight Health, San Francisco, CA Product Marketing Intern, Summer 2014 Partnered with the Product and Sales teams to develop collateral for recent and product releases. Drove the creation and operationalization of customer case studies in coordination with Sales Senior Leadership, Corporate Marketing, and Customer Success.

Cornerstone Investment Partners, Atlanta, GA Summer Associate, Summer 2014 Performed fundamental analysis of domestic equities for $9B fund. Constructed buy, sell, hold, and recommendations for 30+ stocks, and presented them to the portfolio managers.

Omada Health, San Francisco, CA Business Development Consultant, Summer 2013 Collaborated with Co-Founders, VP of Marketing, and VP of Sales to develop a multi-year business plan strategy: outlined sales process and target market, and developed pricing strategy. Assessed market competition and product positioning, and established strategic partnerships with wellness companies and benefits consultants to leverage synergies among product and service offerings. 

Tiger Global Management, New York, NY Analyst Intern, Spring Semester 2014 Worked 10-20 hours per week during the spring semester. Conducted primary research, reference checks and built financial models for equity investment ideas in various industries.

Genentech Inc., South San Francisco, CA Business Development Intern, Summer 2014 Assisted deal teams in four licensing, acquisition, and collaboration deals by conducting scientific, legal and financial due diligence, drafting term sheets, and ing negotiations in Immunology and Infectious Diseases spaces. Evaluated potential partnerships and deal structures to enable microbiome research and presented recommendations to senior leadership. Frankel Group LLC, New York, NY Senior Associate, 2012-2013 Associate, 2011-2012 Analyst, 2010-2011 Provided strategic recommendations to guide pharmaceutical and biotech companies’ global R&D investments. Developed 9-year renal disease business strategy totaling $8B in revenue for Fortune 50 pharmaceutical company; analyzed market research and secondary data to develop $2B revenue model for immune-based renal diseases. Created investor presentation for a development stage biotech and collaborated with CEO to determine differentiating properties of novel drug and appropriate level of clinical data disclosure for a non-scientific audience. Led team in conducting 150 primary interviews targeting physicians, patients, and payers; synthesized findings to develop orphan disease business strategy for Fortune 50 pharmaceutical company.

Mercer, San Francisco, CA Senior Associate, 2013 Associate, 2011-2013 Senior Analyst, 2010-2011 Analyst, 2008-2010 Consulted self-funded employers  (ranging from 2,000 to 150,000 employees) in solving major healthcare service, cost, and istration issues. Proposed solutions to address the short and long term implications of healthcare reform, and managed  cross-functional teams of experts in law, pharmacy, and wellness as well as vendor managers and implementation leads. Led the West Coast offices in Data Warehouse & Healthcare Analytics sales and implementations.

NCDR, LLC (dba Kool Smiles), Atlanta, GA Business Development Manager, 2012-2013 Senior Financial Analyst, 2010-2012 Led team of 7 during pilot and expansion of orthodontic program. Created pricing, roll-out, and capital spending strategies and presented recommendations to executive management team. After receiving approval, grew program from pilot in 2 offices representing $200,000 of revenues to 14 offices representing $2M of revenues in 6 months. Summit Partners, Palo Alto, CA Associate, 2007-2009 Originated and executed healthcare private equity investments. Led reimbursement, market, regulatory, and financial due diligence efforts. Conducted primary interviews, wrote investment memorandums, and modeled deal return scenarios. Originated 11 Letters of Intent representing $1B of Summit Partners’ capital.

23

Charlie A. Robinson

Alexander V. Rupert

Ankit Saxena

[email protected] Indian Institute of Technology (IIT), New Delhi, India Dual Degree Bachelor and Master of Technology, Biochemical Engineering & Biotechnology, 2009

An opportunity to improve healthcare delivery through innovations in care management, informatics, patient engagement, data connectivity, and insurance programs.

An opportunity with a hedge fund investing across the capital structure.

An opportunity to improve the interactions among various stakeholders within the healthcare value chain.

Aetna able Care Solutions, Boston, MA Product Strategy Intern, Summer 2014 Developed product concept to able care organizations, including recommendations for technology utilization, partnerships, and implementation; ed development of external partnerships designed to enhance able care organizations. The Advisory Board Company, Washington, DC / Austin, TX Dedicated Advisor, Performance Technologies, 2011-2013 Worked on a team that launched a new business intelligence tool designed to empower a data-driven approach to physician network development; analyzed large data sets, developed work plans, and provided execution for program improvements. Associate, Analyst, & Senior Analyst, Research & Insights, 2008-2011 Developed hospital strategies for clinical technology adoption and specialty program development; used pro-forma modeling to inform technology and infrastructure investments; led a team specializing in minimally invasive surgery, obesity, and chronic disease management. Wharton Center for Health Management & Economics, Philadelphia, PA Researcher, 2007-2009 Explored success and failure of venture capital-funded healthcare companies; published article in Health Affairs, January 2009.

24

King Street Capital Management, London, UK Summer Associate, 2014 Generated investment ideas in the paper and packaging and European airlines spaces, presenting recommendations to the Investment Committee. Met with management teams and consulted industry experts to discover business risks and opportunities. Created detailed operating models and analyzed capital structure alternatives including rights offerings. Taconic Capital Advisors, New York, NY Associate, 2011-2013 Worked with fund Partners on distressed credit opportunities and long-short equity positions. Developed recovery model to determine value of unsecured claims at various entities in the American Airlines capital structure. Investigated Monster Beverage Corp’s convenience store sales strategy to model growth opportunity. Assessed widespread media reports regarding health hazards associated with energy drinks. Research led to a $50M equity long position. The Blackstone Group, New York, NY Analyst, 2009-2011 Collaborated with management teams of automotive and insurance companies to create financial models and business plans for corporate restructurings. Formulated strategies to negotiate with stakeholders and regulators. J.P. Morgan, New York, NY Analyst, 2007-2009 Performed credit reviews for J.P. Morgan’s technology, media, and telecommunications loan portfolio. Wrote a weekly update for report to CEO on restructuring situations.

Strategy& (formerly Booz & Company), New York, NY Associate, Summer 2014 Analyzed network strategy at a major health insurer to achieve 15% medical cost saving for launch of a $5B consumerdirected business. Developed hypothesis and analysis framework for savings in Durable Medical Equipment, and Specialty Care Services. SQZ Biotechnologies, Boston, MA Marketing Head, 2013-2014 Developed two-part marketing strategy: 1) Outbound marketing initiatives such as vendor shows that resulted in 30 active customers within first 8 months of operations; 2) Inbound marketing initiatives via SEO and customer analytics (impressions, click-through rate, and conversions), that resulted in 2x growth in traffic in 2 months. Novartis Vaccines & Diagnostics, Raleigh, NC Global Value Chain Manager-Influenza Portfolio, 2011-2013 Global Technical Leadership Program Associate, 2009-2011 Led planning, execution and issue management for portfolio comprising 6 influenza vaccine products ing for 25% of revenue for the division. Managed cross-functional projects in supply chain, manufacturing, engineering, and finance across U.S.A., U.K., Italy, India, and .

Matthew L. Schulz [email protected] Carnegie Mellon University, Pittsburgh, PA B.S., University Honors, Business istration (Finance), 2008

An opportunity with a private equity fund investing in the healthcare sector. Teladoc, Greenwich, CT MBA Associate, Summer 2014 Constructed business plan and projection model for a contemplated behavioral health product offering. Assessed acquisition opportunities and evaluated new revenue models. Sourced potential investors and negotiated term sheets for Series F fundraise. Altaris Capital Partners, New York, NY Associate, 2011-2013 Assessed and executed new healthcare acquisition opportunities. Drafted transaction documents, arranged debt financing, managed diligence work flow, and built investment models. Monitored existing portfolio companies by attending board meetings, performing valuation analyses, and reviewing strategic opportunities with management. Assisted in fundraising process for Altaris’ third fund. Closed four deals including two LBOs, one add-on, and one exit. Leerink Partners / Merrill Lynch, New York, NY Analyst, 2008-2011 Analyzed equity, equity-linked and debt financing alternatives, merger consequences, private equity investments, and IPO scenarios for companies across the healthcare industry. ed a group of over 20 investment bankers from Merrill Lynch who assumed leadership of the investment banking platform at Leerink Partners. Closed four deals including three M&A transactions and one equity offering.

Bedir W. Shather, M.D.

Adam R. Sinensky [email protected] University of Leeds Medical School, Leeds, UK M.D., 2009 Imperial College London, London, UK B.Sc. Medical Sciences and Management, 2007

An opportunity to help build an innovative health care company through a business development role.

A role blending strategy and operations for a provider focused healthcare IT solution.

J.P. Morgan, San Francisco, CA Summer Associate in Health Care Investment Banking, Summer 2014 Advised clients in the biotechnology, medical devices and diagnostics industries. Performed financial analyses including DCF and trading comparables for an $80M private placement round for an innovative diagnostics company. Performed sum of the parts DCF valuation as part of a defense strategy for an $8.9B biotechnology company. Led the creation of a buy-side M&A ideas pitchbook, conducting due diligence on over 30 potential acquisition targets for a $1.2B biotechnology company.

Valence Health, Chicago, IL Product Definition Intern, Summer 2014 Established standard operating procedures for demonstrating suite of health provider IT products to customers. Wrote requirements documentation for development of 5 new product features leveraging Agile process. ed product experience overhaul, including development of personas and interface redesign.

Life Technologies, San Diego, CA & London, UK Associate to the Chief Medical Officer, 2012-2013 Part of a clinical team tasked with identifying target areas for product development. Worked with R&D team to build models to identify target biomarkers, leading to the creation of 3 oncology tests used by a number of academic medical centers. Led the development of a clinical marketing campaign for the company’s first appearance at the ASCO. National Health Service, London, UK Senior house physician (resident) 2009-2011 Prioritized, diagnosed, and treated inpatient issions across a variety of specialties in internal medicine and general surgery. Delivered clinical results while working to tight deadlines in a highly pressured environment.

Navigant Consulting Life Sciences Advisory Services, New York, NY / San Francisco, CA Associate Director, 2013 Managing Consultant, 2010-2013 Senior Consultant, 2009-2010 Commercial and business development consultant for life sciences organizations. Managed internal teams and external relationships for up to 8 concurrent client engagements. Launched San Francisco office as day-to-day leader; integral in growth to 7 employees and ~10% of practice’s revenues within first year. Led multiple long-term client relationships, encoming multiple follow-on projects. ZS Associates, New York, NY Associate Consultant, 2007-2009 Associate, 2005-2007 Provided sales and marketing strategic advice to top pharmaceutical and biotechnology companies. Managed client relationships and internal project teams as large as 5-6 employees globally and officially mentored 3 junior employees.

25

Tejus B. Ujjani

[email protected] Boston University – School of Management, Boston, MA B.S., Magna Cum Laude, Business, 2004

An opportunity to build successful businesses through health care focused private equity investing.

An opportunity to research and evaluate investments in public and private health care companies.

An opportunity to further innovation in healthcare technology, whether as an investor or operator.

NaviMed Capital, Washington, DC Summer Associate, Summer 2014 Worked with founding partner of healthcare-focused growth equity fund to manage due diligence process for an investment in the roll-up of several healthcare services companies. Built financial model, developed financing materials to raise capital and worked directly with management teams. Researched industry landscape, identifying 20+ investment opportunities.

Valo Group, Philadelphia, PA Investment Analyst Intern, Summer 2014-Present Evaluated equity and credit investments in both health care and retail companies for value-oriented, long / short hedge fund. Performed market sizing, researched SEC filings and built detailed financial models to inform analyses and provide recommendations directly to portfolio manager.

Longitude Capital, Menlo Park, CA Summer Associate, Summer 2014 Built the foundation and investment strategy for the $710M firm’s newlyformed health IT vertical. Created and executed a thesis-based deal sourcing effort by mapping the sector, its themes, and its 1,000+ companies. Established the vertical’s advisory network of 20+ former entrepreneurs, industry leaders, and investors. Proactively sourced 8 investment opportunities and performed due diligence. Worked directly with partners and managed two junior interns.

HarbourVest Partners, Boston, MA Direct Investment Associate, 2011-2013 Sourced, evaluated and monitored growth equity, buyout, and mezzanine private equity investments for Direct Investment Group with ~$1.5B dedicated capital. Evaluated 150 new opportunities and performed due diligence, created financial analyses and presented 13 prospective investments to Investment Committee, gaining approvals for 5 initial investments (1 healthcare services company). Active board involvement on 3 portfolio companies. Completed 2 follow-ons and refinancing for ReCommunity, creating the largest independent recycling company in the U.S. Wells Fargo Securities, Charlotte, NC Healthcare Investment Banking Analyst, 2009-2011 Top 10% of analyst class. Analyzed companies using comparable company, discounted cash flow, accretion/dilution, merger and leveraged buyout analyses for M&A transactions and debt and equity financings for life sciences companies.

26

Daniel P. van den Bergh

Laura G. Swearingen

Deloitte Corporate Finance (Health Care & Life Sciences Practice), New York, NY Vice President, 2011 – 2013 Associate, 2008 – 2011 Analyst, 2006 – 2008 Provided financial advisory services to public and private health care clients regarding mergers, acquisitions, divestitures/carve-outs and t ventures. Led deal team in advising not-for-profit health care system ($7B Revenue) in execution of multiple acquisitions and t ventures (e.g. surgery centers, radiology, radiation oncology, dialysis, anesthesia, and group physician practices). AT&T Corporate, Financial Leadership Program, Bedminster, NJ Corporate Finance Specialist, 2005-2006 Associate, 2004-2005 One of seven undergraduates recruited nationwide for executive development program with rotational assignments. Strategic Venture Fund – Built valuation models and evaluated startup companies as potential investments for AT&T’s venture capital fund. Corporate Strategy - ed Director in analyzing business models around new, confidential media technologies for CEO, David Dorman.

[email protected] Cornell University, Ithaca, NY B.S., Biological Engineering, 2007

Safeguard Scientifics, Wayne, PA Associate, 2011-2013 Performed 8 venture capital deployments and an exit totaling $850M+ in transaction value in biopharma, medtech, diagnostics, and health IT. Performed due diligence on investment opportunities. Drafted investment memos and term sheets. Built financial models and cap tables. Rebuilt the firm’s backbone capital deployment and returns model. Worked with leadership of portfolio companies on strategic projects. EuroConsult, New York, NY Associate, 2009-2011 Led cross-border M&A transactions for private equity and Fortune 500 clients in pharma and medtech. Managed a team of analysts. Citigroup, London, UK / New York, NY Analyst, 2007-2009 Active participant on deal teams originating and executing M&A transactions in the healthcare sector across the U.S., European and emerging markets.

David S. Wagner

Ying Yang

Rada Yovovich

[email protected] University of Chicago, Chicago IL AB Fundamentals: Issues & Texts, 2006

A direct investing opportunity with exposure to the healthcare sector.

An opportunity in strategy or business development to bridge developed and emerging markets in the healthcare industry.

An opportunity focused on innovation in health care delivery, particularly at the point of service, with experience in big data analytics, supply chain, clinical and non-clinical process improvement, and revenue cycle.

Fidelity Investments, Boston, MA Summer Equity Analyst, Summer 2014 Performed fundamental equity analysis on domestic stocks in the retail sector. Constructed buy/sell recommendations for four stocks and pitched them to portfolio managers. Developed and presented industry overview presentation of discount retail sector to portfolio managers and President of Equity Division.   PAR Capital Management, Boston, MA Summer Analyst, Summer 2013 Member of investment team at longshort equity hedge fund with over $3.5B in assets. Constructed financial models and performed detailed analyses by developing bottom-up forecasts to assess sensitivity to key drivers and to identify upside/downside potential of investment opportunities. Putnam Associates, Boston, MA Consultant, 2009-2013 Advised leading pharmaceutical and biotech clients on growth strategies, therapeutic area strategies, and pricing and reimbursement strategies, in both international and domestic markets. Constructed financial models and Monte-Carlo simulations to forecast value of pricing and contracting strategies, potential biosimilar competition, and impact of generic competition. Awarded 2011 Putnam MVP honor as distinction of top performance out of all employees.

Novartis AG, Basel, Switzerland MBA intern, Corporate Strategy, Summer 2014 Helped with 5-year strategic planning across all divisions and geographies in Novartis. Coordinated a global project on real-world outcomes across US, Brazil, UK and . Analysis influenced senior decision making, changed forecast, and shifted spending. McKinsey & Company, New York, NY / Shanghai China Associate, 2013 Business Analyst, 2010-2012 Distinctive analyst directly promoted to Associate and the only transferee from Greater China to the US in 2012. Focused on multinational pharmaceutical companies. Key projects included commercial excellence (e.g., sales force effectiveness, marketing strategy), business development (e.g., M&A target screening, licensing), and emerging market strategy (e.g., entry and expansion strategy, local partnership). Extensive field experience with sales representatives and physicians.

The Children’s Hospital of Philadelphia, Philadelphia, PA Summer Intern, 2014 Worked with the VP of Medical Affairs to develop a program for physician leadership education, including a needs assessment, content design, delivery model, and communication strategy. Worked collaboratively to integrate the perspectives of a comprehensive variety of stakeholders throughout the academic medical center, ranging from nurse and physician staff to the senior leadership team. athenahealth, Watertown, MA Senior Manager, 2011-2013 ed senior leadership team as strategic subject matter expert on revenue cycle big data performance measurement, analysis, and reporting across athena client base representing over 50,000 physicians. Delivered performance improvement reports, including implementation plans and detailed impact projections to organizations ranging from 2-physician practices to 93-hospital health systems. Huron Consulting Group, Chicago, IL Manager, 2006-2011 Delivered supply chain, materials management, and strategic sourcing cost management strategies to senior leadership teams at client health systems ranging from single hospitals to 70facility national healthcare institutions. Conducted cost savings strategies worth as much as $65M annually recurring savings, including identification, assessment, implementation, and ongoing monitoring efforts.

27

2014 Internship Sponsors The following organizations provided internships for Health Care Management Students in Summer, 2014.

AETNA ABLE CARE SOLUTIONS Boston, MA Hartford, CT ALBRIGHT STONEBRIDGE GROUP Washington, DC APPLE TREE PARTNERS Princeton, NJ ATHENAHEALTH Watertown, MA AUGMEDIX San Francisco, CA BANK OF AMERICA MERRILL LYNCH Palo Alto, CA BECTON DICKINSON Franklin Lakes, NJ BIOGEN IDEC Cambridge, MA BOOZ & COMPANY (NKA STRATEGY&) New York, NY

CRESSEY & CO. Chicago, IL

MOUNT KELLETT CAPITAL MANAGEMENT New York, NY

DAVITA HEALTHCARE PARTNERS Denver, CO

NAVIMED CAPITAL Washington, DC

DELOITTE CONSULTING New York, NY

NOVARTIS AG Basel, Switzerland

FIDELITY INVESTMENTS Boston, MA

PFIZER New York, NY

FITLY Philadelphia, PA

PUTNAM INVESTMENTS Boston, MA

GENENTECH INC. South San Francisco, CA

QUANTIA INC. Waltham, MA

GENZYME, A SANOFI COMPANY Cambridge, MA

RAYMOND JAMES Nashville, TN

GLENHILL CAPITAL New York, NY

TELADOC Greenwich, CT

GOOGLE Mountain View, CA

UNIVERSITY OF COLORADO, DEPARTMENT OF MEDICINE Aurora, CO

HEALTH ENTERPRISE PARTNERS New York, NY HEALTH ESSENTIALS LLC Santa Ana, CA

UNIVERSITY OF PITTSBURGH MEDICAL CENTER Pittsburgh, PA

THE BOSTON CONSULTING GROUP Shanghai, China

HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA, CENTER FOR SURGERY AND HEALTH ECONOMICS Philadelphia, PA

BRISTOL-MYERS SQUIBB Plainsboro, NJ

INFOSYS LIMITED Pune, India

CASTLIGHT HEALTH San Francisco, CA

JOHNSON & JOHNSON – JANSSEN BIOTECH INC. Horsham, PA

WALMART ECOMMERCE San Bruno, CA

J.P. MORGAN San Francisco, CA

WELLS FARGO SECURITIES San Francisco, CA

KAISER PERMANENTE Oakland, CA

ZALORA Jakarta, Indonesia

CEDARS-SINAI HEALTH SYSTEM Los Angeles, CA CELGENE CORPORATION Summit, NJ CELGENE CELLULAR THERAPEUTICS Warren, NJ THE CHILDREN’S HOSPITAL OF PHILADELPHIA Philadelphia, PA CITADEL INVESTMENT GROUP New York, NY CORNERSTONE INVESTMENT PARTNERS Atlanta, GA

KING STREET CAPITAL MANAGEMENT London, UK LONGITUDE CAPITAL Menlo Park, CA MCKINSEY & COMPANY Palo Alto, CA Washington, DC Atlanta, GA Moscow, Russia MEDTRONIC Northridge, CA Minneapolis, MN

28

UNIVERSITY OF PENNSYLVANIA HEALTH SYSTEM PHILADELPHIA, PA

VALENCE HEALTH Chicago, IL VALO GROUP Philadelphia, PA

2014 Health Care Program Mentors Mentors are leaders and senior managers in the health care field who have agreed to provide career and professional development advice and guidance to Health Care Management Students.

SEBASTIAN AGUILAR GARCIA Associate A.T. Kearney Mexico City, Mexico SHEENA ASHOK Senior Consultant Kaiser Permanente-Southern California Permanente Medical Group (SMG) Pasadena, CA VIKRAM D. BAKHRU, MD Chief Medical Officer First Opinion San Francisco, CA TONY BALDA President & COO Medicomp, Inc. Melbourne, FL JOHN BARKETT Director of Product Marketing and Policy Affairs Towers Watson Exchange Solutions Washington, DC MEGAN UNTALAN BARKETT Chief of Staff to CEO The Advisory Board Company Washington, DC PETER R. BARNETT, DMD President Star Ranch Dental Plano, TX GRANT BECHTOLD Vice President of Business Operations / Corporate Development Medsurant Holdings, LLC (portfolio company of New Capital Partners) Denver, CO

RYAN BERGER Senior Business Analyst Hearst Health Innovation Lab Los Angeles, CA

WILLS CHANDLER Vice President of Health System Alliance CVS Caremark Cumberland, RI

ALEXIS BERNSTEIN Director, Strategy & Operations, able Care Solutions Aetna Boston, MA

DEEP CHARAN, MD Resident Physician UCLA Los Angeles, CA

DEEPA BHAT Product Manager Genentech South San Francisco, CA

THIERRY CHAUCHÉ Executive Director, Business Planning & Analysis Novartis Pharmaceuticals East Hanover, NJ

MITCHELL BLUTT, MD CEO Consonance Capital New York, NY

EMILY COUEIGNOUX CHEN Senior Manager, Market Planning Seattle Genetics Bothwell, WA

DANIEL BRANCO Founder & CEO DMBranco Healthcare Investments & Advisory/Medicinia Digital Medicine São Paulo, Brazil

MARK CHIN Vice President Longitude Capital Menlo Park, CA

SAM BRASCH Director Kaiser Permanente Ventures Oakland, CA JOHN BRODSKY President Fairmount Capital Advisors, Inc. Philadelphia, PA LUCAS BUCHANAN Executive Vice President, Corporate Development and Commercialization; Executive in Residence Silk Road Medical, Inc.; Warburg Pincus Sunnyvale, CA ALEX BUZIK Managing Director MTS Health Investors New York, NY ELIZABETH J. CAMPBELL Principal SV Life Sciences Advisors, LLC Boston, MA

JAMIL BEG Director, Business Development Sage Therapeutics, Inc. Cambridge, MA

NICOLE CARKNER Executive Director Quad City Health Initiative Davenport, IA

ALI BEHBAHANI, MD Partner NEA Chevy Chase, MD

EDWARD CHAN Senior Associate NaviMed Capital Rosslyn, VA

ERIC BELL Senior Director Intellectual Ventures Seattle, WA

BRIAN G. CHOI, MD Associate Professor of Medicine & Radiology George Washington University Washington, DC EDDIE CISNEROS Vice President, Business Development DAVITA HEALTHCARE PARTNERS Chicago, IL RYAN COCHRAN Associate New Leaf Venture Partners New York, NY BRETT COHEN Corporate Vice President Fresenius Medical Care Waltham, MA CAROLYN COLACICCO Senior Manager TriVascular Santa Rosa, CA DANIEL J. CURRAN, MD Vice President, Therapeutic Area Lead Takeda Pharmaceutical Company Cambridge, MA JAY DESAI Entrepreneur PatientPing Boston, MA SALIL V. DESHPANDE, MD Chief Medical Officer UnitedHealthcare Community Plan of Texas Houston, TX continued on next page

29

Health Care Program Mentors PITAMBER “PITOU” DEVGON, MD Co-Founder Creative Vascular, Inc. Philadelphia, PA CHRIS DUKE Executive Director International Commercial Relations NPS Pharmaceuticals Bedminster, NJ CATHY K. EDDY President Health Plan Alliance Irving, TX BRANDON EINSTEIN Associate Goldman Sachs New York, NY RAMI ELGHANDOUR Chief Business Officer Nevro Menlo Park, CA MYRIAN EXUME Director, Global Commercialization Bristol-Myers Squibb Princeton, NJ DANIEL FAGA Principal Centerview Partners San Francisco, CA MING FANG Principal Safeguard Scientifics, Inc. Wayne, PA MICHAEL FAZEKAS Vice President Flexpoint Ford, LLC Chicago, IL

MIHIR C. GANDHI Director, Healthcare Venture Investments AVIA Innovation Accelerator Chicago, IL MICHAL GATTNAR Managing Director Pavis Capital Mill Valley, CA SIMEON J. GEORGE, MD Partner SR One Ltd San Francisco, CA KYLE GILBRIDE Senior Associate HEALTHAGEN, a subsidiary of Aetna New York, NY LETICIA LAZARIDIS GOLDBERG Investment Management Earnest Partners - Brazil Office Rio de Janeiro, Brazil BRIAN P. GOLDSTEIN, MD Executive Vice President and Chief Operating Officer UNC Hospitals Chapel Hill, NC VIKAS GOYAL Associate SR One Cambridge, MA

VLAD HOGENHUIS, MD Senior Vice President, Global Franchise Leader CardioVascular GlaxoSmithKline Brentford, UK SAM HOLLIDAY Vice President, Corporate Development & Strategy Everyday Health New York, NY TODD HOLMES Director Gurnet Point Capital Boston, MA BRIAN HOLZER Senior Vice President, Diversified Businesses Allegheny Health Network Pittsburgh, PA JARED HOPKINS Director Strategic Finance and Business Consulting University of Michigan Health System Ann Arbor, MI NOUHAD HUSSEINI Senior Director, Business Development Regeneron Pharmaceuticals Tarrytown, NY EMILY COOPER JANVEY Vice President TPG Special Situations Partners San Francisco, CA

TODD GUREN Product Development Manager Providence Health Plans Portland, OR

MAGGIE HILL JARRETT Senior Manager, Corporate Strategy & Business Development McKesson Denver, CO

PHILIP GUTRY Principal MPM Capital South San Francisco, CA

PRASHANTH JAYARAM Healthcare Analyst Citadel Group New York, NY

DOUGLAS C. FISHER, MD Partner InterWest Partners Menlo Park, CA

JOHN HARRIS Principal DGA Partners Bala Cynwyd, PA

PETER FISHMAN Founder Tolograph New York, NY

BOSUN HAU Partner MVM Life Science Partners Boston, MA

VIVEK K. JAYARAMAN Vice President – Global Sales & Marketing TriVascular, Inc. Santa Rosa, CA

AARON FLINK Sr. Manager, Corp. Strategy and Business Development McKesson San Francisco, CA

DAVID HECHT Vice President Formation Capital Alpharetta, GA

EVAN S. FIELDSTON, MD Assistant Professor of Pediatrics, Perelman School of Medicine; Attending Physician General Pediatrics, Director Care Model Innovation, The Children’s Hospital of Philadelphia Philadelphia, PA

CHRIS FRANCK Partner, Life Sciences & Health Care Deloitte Consulting, LLP Parsippany, NJ

30

SARAH FREW Director, Business and Commercial Development Tetralogic Pharmaceuticals Malvern, PA

CARRIE HIEBELER Senior Investment Officer Ventas, Inc. Chicago, IL

PHIL HEIFETZ President and CEO EyelC, Inc. W. Conshohocken, PA

TRACY K. JOHNSON Vice President Health Strategies and Solutions Philadelphia, PA FABIO ALEXANDRE JUNG Director/Investment Banking Brazil Deutsche Bank São Paulo, Brazil KARL M. KELLNER Director McKinsey & Company, Inc. New York, NY

RON C. KERO Vice President, Business Development & Operations VHA West Coast Insurance & Financial Services Renton, WA RUHI KHAN Vice President, Business Development Acorda Therapeutics Hawthorne, NY DAVID KIBBE Divisional Vice President, Acute Care Universal Health Services King of Prussia, PA MIKE KIJEWSKI Founder Gamma Basics Carlsbad, CA JOYCE KIM Senior Managerial Consultant Kaiser Permanente Ventures Oakland, CA STEPHEN KIM Associate Goldman, Sachs & Co. New York, NY RYAN KIRKPATRICK Partner Colorado Impact Fund Denver, CO DAVE KONCIAK Director, Strategic Analytics Bristol-Myers Squibb Lawrenceville, NJ ADAM M. KOPPEL, MD, PHD Chief Strategy Officer & Senior Vice President Biogen Idec Boston, MA MICHELLE LEE Consultant Kaiser Permanente Performance Excellence San Francisco, CA RICHARD LEE, MD Assistant Professor Weill Cornell Medical College New York, NY ELIZABETH LEIDERMAN, MD Vice President Nomura New York, NY

LAUREN LISHER Senior Director RelayHealth/McKesson Corporation Emeryville, CA

WESLEY NURSS Associate ISI Group New York, NY

WENDY LIU Vice President HealthCare Royalty Partners Stamford, CT

JAMES O’CONNELL Principal Safeguard Scientifics, Inc. Wayne, PA

MARK A. LYLES, MD Chief Strategic Officer Medical University of South Carolina Charleston, SC

JENNIFER O’NEILL Brand Manager, Effient Daiichi Sankyo Inc. Parsippany, NJ

CAROLYN MAGILL Senior Vice President, Payer Strategy & Operations Evolent Health Arlington, VA

CARY PFEFFER, MD Partner Third Rock Ventures Boston, MA

JEFFREY D. MARRAZZO President and CEO Spark Therapeutics Inc. Philadelphia, PA

GARY M. PHILLIPS, MD Senior Vice President and Chief Strategy Officer Mallinckrodt Pharmaceuticals Hazelwood, MO

ALISON MARX Operating Officer, Dept. of Pediatrics The Children’s Hospital of Philadelphia Philadelphia, PA

JOHN PICASSO Senior Associate Fifth Street Management LLC White Planis, NY

GREGG MCCONNELL Sr. Manager, Business Development Pfizer New York, NY

SALLY POBLETE Founder and CEO Wellthie Inc. New York, NY

ROBERT C. MCDONALD, MD President Aledo Consulting, Inc. Indianapolis, IN

LEN PODOLSKY Director of Operations Connolly, LLC Conshohocken, PA

REGAN MURPHY Chief of Staff / Client Manager Valence Health Chicago, IL

AMIKA PORWAL Senior Associate Booz & Company Chicago, IL

HAREESH NAIR Vice President Quadria Capital Investment Mgmt. Pte Ltd Singapore

KEVIN PYUN Managing Director Consonance Capital Investors New York, NY

DAVID B. NASH, MD Dean, Jefferson School of Population Health Thomas Jefferson University Philadelphia, PA

LISA RAMON Health Systems and Services Expert for Latin America McKinsey & Company Mexico City, Mexico

TY NELSON Executive Vice President Operations Health Carousel LLC Cincinnati, OH

ADAM LESSLER Engagement Manager McKinsey & Company Philadelphia, PA

PRASHANT NIKAM Director, Global Commercial Leader, Mozobil & Legacy Brands Sanofi Cambridge, MA

MICHAEL LI Portfolio Manager American Century Investments Kansas City, MO

TATIANA NIKITINA Chief Marketing Officer xG Health Solutions New York, NY

OSCAR LIN Analyst Axial Capital New York, NY

PRIYA NILEKANI Senior Managerial Consultant Kaiser Permanente Oakland, CA

LINDSAY RAND Senior Manager, Strategic Initiatives Office University of Chicago Medicine Chicago, IL DONNA BRADY RAZIANO, MD Chief Medical Officer Mercy Home System, Mercy Home and Community Health Services Philadelphia, PA ERIC REDLINE Vice President Client Delivery Pharma Metrics Fort Washington, PA JOSHUA RESNICK, MD Venture Partner, Atlas Venture; CEO, Ataxion Therapeutics Cambridge, MA continued on next page

31

BEN RHEE Senior Manager – Life Sciences Strategy Accenture Philadelphia, PA JAMES RHODES Senior Consultant Deloitte Consulting LLP Dallas, TX JAMES F. RICHTER Vice President Business Development RedMed Paoli, PA

AMANDA HOPKINS TIRRELL Chief Operating Officer Georgia Regents Medical Associates, Medical College of Georgia Augusta, GA

ANNE SISSEL Vice President Dean Bradley Osborne San Francisco, CA

ERIC TRÉPANIER Vice President, Commercial Clinical Strategy & Analytics WebMD/Medscope New York, NY

JONTHAN SOLOMONS President & CEO Tabor Children’s Services Philadelphia, PA

SAFIA K. RIZVI Managing Director UCB India Private Limited Mumbai, India

MAUREEN A. SPIVACK Managing Director KPMG Corporate Finance LLC New York, NY

EDMONDO J. ROBINSON, MD Associate Chief Medical Officer, Physician in Chief Christiana Care Health System Wilmington, DE

BHUVAN SRINIVASAN Associate KKR Mumbai, India

PAMELA RODMAN istrative Director Columbia University New York, NY BENJAMIN ROOKS Managing Director ST Advisors, Inc. San Francisco, CA MICHAEL ROVINSKY Executive Director, Strategic Planning Kaiser Permanente of the Mid-Atlantic States Rockville, MD ANIL SAGGI M&A Director Novartis Stockholm, Sweden DAVID SCHUPPAN Partner Cressey & Company LP Chicago, IL SVEN SEYFFERT Senior Business Director Medtronic Singapore AMIT B. SHAH, MD Associate Principal McKinsey & Company New York, NY ANKIT SHAH Sr. Marketing Manager Intersect ENT Menlo Park, CA JONATHAN SHANNON Executive Director Universal American (Collaborative Health Systems) Atlanta, GA SHAFINA SHEHNAZ Vice President Goldman Sachs & Co. New York, NY

32

DAVID SILK Director Digital Acceleration, US Marketing Pfizer New York, NY

JAMES STANFORD Principal Fitzroy Health Upper Montclair, NJ MEIR STEIN Director of Marketing Development Satellite Healthcare San Jose, CA JÉRÔME STEVENS, MD CEO Patientys (subsidiary of Direct Medcica Group) Boulogone, SCOT STEVENS Public Equity Partner Orbi Med Advisors LLC New York, NY PATRICK SULLIVAN Vice President GMT Capital Corp. New York, NY RUTH SUTER Senior Director, Market Access and Patient Services BioMarin Pharmaceutical Inc. Novato, CA VIC TANDON Sr. Manager, Health and IT Strategy West Health Institute La Jolla, CA JARED TEO Sr. Program Officer California Health Care Foundation San Francisco, CA PAUL V. THOMAS Business Unit Head – Biosimilars Biocon Ltd. Bangalore, India PAUL TIRJAN Vice President, Ambulatory Care Universal Health Services, Inc. King of Prussia, PA

JOHN URQUHART Senior Associate HealthCare Royalty Partners Stamford, CT LISA VARSHNEY Associate Partner Rosetta Marketing Strategy & Insights Practice New York, NY DAVID WALTON Chief Commercial Officer AgaMatrix Salem, NH JASON WEIDMAN Vice President and General Manager, Medtronic Coronary Vascular Medtronic Santa Rosa, CA CHRIS WILKERSON President EquipSystems, LLC New York, NY JOHN WINKELMAN President Winkelman Associates Inc. Irvine, CA ANDREW W. WONG Vice President, Business Development SciClone Pharmaceuticals, Inc. Shanghai, China DANIEL YIP Senior Director, Global Marketing Intercept Pharmaceuticals New York, NY STEPHEN E. YODER, MD Global Lead, CV/Metabolic Search & Evaluation, Bus. Dev. Bristol-Myers Squibb Princeton, NJ ELLEN S. YOON Global Health Care Subject Matter Expert IBM Corp. New York, NY KEELY ZIPP Director Oncology Operations, Global Oncology Franchise GlaxoSmithKline Collegeville, PA THOMAS ZIPP Global Brillinta Business Insight Lead, Brillinta AstraZeneca Wilmington, DE

istration GEOFFREY M. GARRETT, PH.D. Dean, The Wharton School HOWARD KAUFOLD, PH.D. Vice Dean and Director, The Wharton Graduate Division SCOTT E. HARRINGTON, PH.D. Chair, Health Care Management Department, The Wharton School; Director, MBA Program in Health Care Management JUNE M. KINNEY, M.A. Associate Director, MBA Program in Health Care Management CHRISTINE ALESZCZYK istrative Coordinator, MBA Program in Health Care Management JANICE SINGLETON istrative Coordinator, MBA Program in Health Care Management

33

Faculty The Program Faculty are drawn from the Wharton School, the School of Medicine, the School of Nursing, and the School of Arts and Sciences at the University of Pennsylvania and leading health institutions in Philadelphia. Additional is provided by the Fellows and Associates of the Leonard Davis Institute of Health Economics.

EUGENIO ANESSI, PH.D. Professor, Public Management, Bocconi University Graduate School of Management, Milan, Italy; Lecturer and Senior Fellow, Health Care Management, The Wharton School DAVID A. ASCH, M.D., M.B.A. Executive Director, Penn Medicine Center for Health Care Innovation; Professor of Medicine, Perelman School of Medicine at the University of Pennsylvania; Professor, Health Care Management, The Wharton School THOMAS E. BAKER, J.D. William Maul Measey Professor of Law and Health Sciences, University of Pennsylvania Law School; Professor of Health Care Management, The Wharton School LAWTON R. BURNS, PH.D., M.B.A. James Joo-Jin Kim Professor of Health Care Management, The Wharton School; Faculty Co-Director, Roy and Diana Vagelos Program In Life Sciences & Management PATRICIA M. DANZON, PH.D. Celia Z. Moh Professor of Health Care Management and Business Economics, The Wharton School GUY DAVID, PH.D. Associate Professor, Health Care Management, The Wharton School BENJAMIN DORANZ, PH.D., M.B.A. President and CEO, Integral Molecular, Inc.; Senior Fellow, Health Care Management, The Wharton School

34

EZEKIEL J. EMANUEL, M.D., PH.D. Diane v.S. Levy and Robert M. Levy University Professor and Vice Provost for Global Initiatives; Professor, Health Care Management, The Wharton School ROBERT I. FIELD, J.D., PH.D., M.P.H. Professor of Law at the Earle Mack School of Law and Professor of Health Management and Policy at the School of Public Health at Drexel University, Philadelphia; Lecturer, Health Care Management, The Wharton School BRADLEY M. FLUEGEL Senior VP & Chief Strategy Officer, Walgreens; Lecturer, Health Care Management, The Wharton School THOMAS N. GILMORE, M.ARCH. Vice President, The Center for Applied Research Inc.; Senior Fellow, Health Care Management, The Wharton School JOHN P. GLASER, PH.D. Chief Executive Officer, Health Systems Business Unit, Siemens; Lecturer, Health Care Management The Wharton School HENRY A. GLICK, PH.D. Professor of Medicine, Perelman School of Medicine at the University of Pennsylvania; Professor, Health Care Management, The Wharton School MATTHEW R. GRENNAN, PH.D. Assistant Professor, Health Care Management, The Wharton School SCOTT E. HARRINGTON, PH.D. Chair, Health Care Management Department, and Director, Health Care Management Program, The Wharton School Alan B. Miller Professor of Health Care Management and Business Economics and Public Policy, The Wharton School JOHN C. HERSHEY, PH.D. Anhe-Busch Professor Emeritus of Management Science; and Health Care Management, The Wharton School NAOKI IKEGAMI, M.D. Professor, Keio University School of Medicine, Tokyo, Japan; Senior Fellow, Health Care Management, The Wharton School

JOHN KIMBERLY, PH.D. Henry Bower Professor of Entrepreneurial Studies; Professor of Management, Health Care Management, and Sociology, The Wharton School JUNE M. KINNEY, M.A. Associate Director, Graduate Program in Health Care Management; Lecturer, Health Care Management, The Wharton School JONATHAN T. KOLSTAD, PH.D. Assistant Professor, Health Care Management, The Wharton School GARY J. KURTZMAN, M.D. Vice President, Life Sciences, Safeguard Scientifics; Lecturer, Health Care Management, The Wharton School JEFFREY P. LIBSON, J.D. Partner, Pepper Hamilton LLP; Lecturer, Health Care Management, The Wharton School HARI MAHADEVAN, PH.D. Independent Consultant; Lecturer and Senior Fellow, Health Care Management, The Wharton School DANIEL N. MENDELSON. M.P.P. CEO and Chairman, Avalere Health Inc.; Lecturer, Health Care Management; The Wharton School STEVEN A. NICHTBERGER, M.D. Adjunct Professor and Senior Fellow, Health Care Management, The Wharton School MITESH S. PATEL, M.D. Assistant Professor of Medicine, Perelman School of Medicine at the University of Pennsylvania School of Medicine; Assistant Professor of Health Care Management, The Wharton School MARK V. PAULY, PH.D. John M. and Thomas L. Bendheim Professor; Professor, Health Care Management, Business Economics and Public Policy, The Wharton School; Professor, Economics, College of Arts and Sciences WILLIAM P. PIERSKALLA, PH.D. Professor Emeritus DANIEL POLSKY, PH.D. Robert D. Eilers Professor of Health Care Management and Economics, The Wharton School; Professor of Medicine, Perelman School of Medicine at the University of Pennsylvania; Executive Director, Leonard Davis Institute of Health Economics

DOUGLAS A. PRESENT, M.B.A. Independent Consultant; Lecturer, Health Care Management, The Wharton School ARNOLD J. ROSOFF, J.D. Professor Emeritus, Legal Studies and Business Ethics; Lecturer, Health Care Management, The Wharton School STEPHEN M. SAMMUT Lecturer and Senior Fellow, Health Care Management, Lecturer, Entrepreneurial Programs, The Wharton School CYNTHIA SCALZI, M.N., PH.D. Professor Emeritus of Nursing and Health Care Management, The Wharton School

RACHEL M. WERNER, M.D., PH.D Associate Professor of Medicine, Perelman School of Medicine at the University of Pennsylvania School of Medicine; Associate Professor and Senior Fellow, Operations and Information Management, Health Care Management, The Wharton School JOHN J. WHITMAN, M.B.A. Executive Director, The TRECS Institute; Lecturer, Health Care Management, The Wharton School SANKEY V. WILLIAMS, M.D. Sol Katz Professor of General Internal Medicine; Professor, Health Care Management, The Wharton School

J. SANFORD SCHWARTZ, M.D. Leon Hess Professor in Internal Medicine, Perelman School of Medicine at the University of Pennsylvania; Professor, Health Care Management, The Wharton School JEFFREY H. SILBER, M.D., PH.D. Director, Center for Outcomes Research, The Children’s Hospital of Philadelphia; Professor of Pediatrics and Anesthesiology & Critical Care, Perelman School of Medicine at the University of Pennsylvania; Professor, Health Care Management, The Wharton School JEFFREY A. SOLOMON, M.D., M.B.A. Founding Partner, Infiniti Medical LLC; Lecturer, Health Care Management, The Wharton School

JUNE KINNEY Associate Director, MBA Program in Health Care Management The Wharton School

AMANDA STARC, PH.D. Assistant Professor, Health Care Management, The Wharton School ASHLEY SWANSON, PH.D. Assistant Professor, Health Care Management, The Wharton School

Questions or complaints regarding this policy should be directed to: Executive Director, Office of Affirmative Action and Equal Opportunity Programs Sansom Place East 3600 Chestnut Street, Suite 228 Philadelphia, PA 19104-6106 215.898.6993 (Voice) 215.898.7803 (TDD)

ROBERT J. TOWN, PH.D. Associate Professor, Health Care Management The Wharton School KEVIN G.M. VOLPP, M.D., PH.D. Director, Center for Health Incentives and Behavioral Economics, Leonard Davis Institute; Professor of Medicine, Perelman School of Medicine at the University of Pennsylvania; Professor, Health Care Management, The Wharton School

The University of Pennsylvania values diversity and seeks talented students, faculty and staff from diverse backgrounds. The University of Pennsylvania does not discriminate on the basis of race, sex, sexual orientation, gender identity, religion, color, national or ethnic origin, age, disability, or status as a Vietnam Era Veteran or disabled veteran in the istration of educational policies, programs or activities; issions policies; scholarship and loan awards; athletic, or other University istered programs or employment.

SCOTT E. HARRINGTON, PH.D. Director, MBA Program in Health Care Management, The Wharton School

©2004, The Trustees of the University of Pennsylvania. All rights reserved.

Photography of Students: Stuart Watson Book Design: www.HollisterCreative.com

35

Wharton The Wharton School University of Pennsylvania MBA Program in Health Care Management 3641 Locust Walk Philadelphia, PA 19104-6218 215.898.6861 fax 215.573.2157